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Development of a method for the investigation of protein 
carbamylation by CO2  
Joanna Janus 
Abstract 
Protein carbamylation occurs in biological systems when the nitrogen atom of a neutral 
amine group makes a nucleophilic attack upon the carbon atom of a CO2 molecule. This 
results in the CO2 becoming bonded to the amine group as a carbamate. Carbamates play 
important structural and functional roles in several proteins, including haemoglobin, Rubisco 
and β-lactamases. Despite this and the ubiquity of CO2, relatively few proteins have been 
shown to be carbamylated. This is partly due to the labile nature of the carbamate bond, 
meaning it dissociates readily and can be hard to investigate.  
A method was developed to ethylate carbamate modifications on proteins using the reagent 
triethyloxonium tetrafluoroborate (TEO). The ethylation trapped the carbamate modification 
so it could be analysed by mass spectrometry.  It was first confirmed that TEO could trap a 
carbamate on an amino acid, then the trapping method was adapted for use on proteins. It 
was shown that the TEO trapping method was able to stabilise a carbamate on haemoglobin 
which could be detected using MALDI-TOF and electrospray mass spectrometry. The 
method was also used to test proteins with unknown carbamate forming abilities. 
Recombinant proteins comprising the catalytic domains of mammalian transmembrane 
adenylyl cyclases and the related Rv1625c adenylyl cyclase from Mycobacterium 
tuberculosis were expressed and used in the carbamate trapping experiments. The 
Rv1625c204-443 protein was revealed to potentially possess a carbamylated Lys-296 residue. 
Due to inconclusive results an alternative method was used to further explore this result. 
14CO2 was supplied to the wild type Rv1625c204-443 recombinant protein and an Rv1625c204-
443 protein with Lys-296 mutated to Ala, before potential carbamates were trapped with TEO. 
It was concluded that it was likely that the Lys-296 residue of Rv1625c204-443 did not form a 
carbamate, although further work is needed to confirm this result.  
A method has therefore been developed to trap carbamate modifications on proteins and 
has been used to explore whether adenylyl cyclases undergo carbamylation by CO2. The 
method requires further optimisation and some results were inconclusive. However the 
findings from this study will contribute towards the development of a method to screen many 
proteins in a cell lysate for carbamate modifications simultaneously, using proteomic 
techniques.  This will be a valuable tool in enabling us to better understand the extent and 
roles of protein carbamylation in physiology.  
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1.1 Sensing and responding to CO2 
Carbon dioxide (CO2) is a fundamental component of the both the external and internal 
environments of living organisms. CO2 constitutes just 0.04% of the earth’s atmospheric 
gases, and due to its high solubility is found at similar levels in the planets oceans and other 
large bodies of water (Zeebe, 2012). Plants and other photosynthetic organisms such as 
cyanobacteria and algae use CO2 as a substrate for photosynthesis, and so their growth 
and survival are dependent upon a sufficient amount of CO2 present in the atmosphere. 
Many of these photosynthetic organisms also use carbon concentrating mechanisms to 
increase the local concentration of carbon dioxide around the site of the photosynthetic 
enzyme Rubisco (Moroney et al., 2013). Aquatic organisms are also sensitive to 
environmental partial pressures of CO2, as CO2 dissolved in bodies of water is capable of 
forming carbonic acid (Figure 1.1.1). This weak acid can then partly dissociate to form 
protons and bicarbonate ions, lowering the pH of the water which may impact the physiology 
of the organisms within it. For example high CO2 levels have been found to reduce levels of 
reproductivity and growth in several species of marine and freshwater fish, including juvenile 
white sturgeon and perch (Portner et al., 2004)   
 
Animals, plants, fungi and bacteria also produce CO2 as a direct by-product of aerobic 
respiration or indirectly from the oxidation of lactic acid in anaerobic respiration. This can 
lead to the creation of localised concentrations of CO2 within organisms. CO2 produced 
through respiration can dissolve in internal fluids within organisms such as blood and 
cytoplasm, with the resulting acidosis causing potential disruption and damage to cellular 
systems unless it is regulated and removed. Some organisms are able to make use of the 
CO2 emitted by other respiring organisms as an indicator of a potential food source.  
Parasites including  mosquitoes and ticks can use the higher CO2 concentrations 
surrounding their respiring hosts as a sensory cue to guide them towards their host 
(Chaisson and Hallem, 2012), while in other species CO2 elicits an avoidance response 
(Bretscher et al., 2011, Jones et al., 2007) 
Figure 1.1.1: Products of CO2 in solution 
CO2 may combine with water in a reversible reaction to form carbonic 
acid, which can in turn reversibly dissociate to form bicarbonate and a 
proton. CO2 may therefore induce functional effects in organisms via 
pH, bicarbonate or by molecular CO2. 
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Therefore the ability to detect levels of CO2 in both their internal and external environments 
is critical to allow biological organisms to respond accordingly, and there are several 
mechanisms by which they may do this. Gaseous exchange of CO2 between an organism 
and its environment is a direct way of regulating internal CO2 and oxygen levels.  In most 
animals specialised ventilation mechanisms are required to enable gaseous exchange to 
take place efficiently, especially if an organism is undergoing higher levels of respiration 
and so needs to expel greater volumes of CO2 than at its normal resting rate. A key way by 
which animals can regulate ventilation and gaseous exchange in response to CO2 is through 
the detection of pH levels (Nattie, 1999). As already mentioned dissolved CO2 will form an 
acid and produce H+ (Figure 1.1.1). Therefore CO2 from respiring tissue will produce 
protons, which are transported from the cells of the tissue into the blood. In mammals 
chemoreceptors located in the carotid body respond to the increased concentration of H+ 
by stimulating the carotid sinus nerve which relays the impulses to the brainstem, which in 
turn can increase the amount of ventilation to expel the excess CO2 and increase the flow 
of oxygen to the respiring tissues (Nurse and Piskuric, 2013).  
While much research has centred on the control of CO2 responses via pH, there is also 
evidence of molecular CO2 being sensed either directly or through the production of 
bicarbonate ions (Figure 1.1.1).  It has been shown that mice can be trained to respond to 
levels of CO2 as low as 0.06%, with over 90% accuracy (Hu et al., 2007). This ability to 
detect CO2 was shown to occur via activation of a subset of olfactory neurons that express 
guanylyl cyclase D (GCD) (Hu et al., 2007). The response was shown to be independent of 
intracellular and extracellular pH but required the presence of carbonic anhydrase II (CAII) 
activity (Hu et al., 2007). As carbonic anhydrase catalyses the hydration of CO2 into H+ and 
HCO3- ions (Hewett-Emmett and Tashian, 1996) it was hypothesised that either of these 
ions could be causing the CO2 response, although in this study this was not explored further. 
However as the authors had shown that changing the pH when CO2 was absent showed no 
activation of the olfactory neurons, it seems likely that the HCO3- ions were causing the 
response.  
The activation of olfactory receptors by CO2 has also been shown to produce avoidance 
responses to CO2 in Drosophila and C. elegans and to inhibit egg laying in C. elegans 
(Bretscher et al., 2011, Jones et al., 2007, Fenk and de Bono, 2015, Sun et al., 2009). 
However the molecular mechanisms underpinning these responses are still unclear. Often 
they appear to be independent of external pH, however it is much more difficult to monitor 
the internal pH changes within a cell and so it cannot be concluded that pH is not having 
any effect. Additionally in the cases where bicarbonate and/or molecular CO2 are found to 
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be inducing responses it is often hard to distinguish which of these molecules is causing 
the effect. In the case of the mouse GCD olfactory neurons discussed above it was 
concluded that bicarbonate ions were likely to induce the response to CO2 due to a 
dependence on expression of carbonic anhydrase that hydrates CO2 into HCO3- and H+ (Hu 
et al., 2007). However more recently it was shown that the related BAG neurons in C. 
elegans, which also express a membrane bound guanylyl cyclase, were activated by 
molecular CO2 and not bicarbonate, although they could also be activated by acid (Smith et 
al., 2013). Membrane bound guanylyl cyclase 9 but not soluble guanylyl cyclase expression 
was required for the CO2 response to occur, and this response was not dependent on the 
activity of carbonic anhydrase. This suggests that the guanylyl cyclases are acting as a 
direct receptor for CO2 rather than bicarbonate ions, which would be more likely to require 
carbonic anhydrase expression (Smith et al., 2013). In other related studies no attempt is 
made to distinguish whether bicarbonate or CO2 is inducing the response, despite papers 
often implying that bicarbonate is the causative agent, as it is used as the source of CO2 in 
many studies (Sun et al., 2009, Hallem et al., 2011) 
Therefore it is clear from these examples that if we are to be able to better understand the 
mechanisms behind cellular responses to CO2, it is necessary to determine precisely how 
CO2 and/or its derivatives are initiating a signalling response. One way in which molecular 
CO2 is known to be able to bind to and alter the properties of proteins is via the formation of 
a carbamate modification. The role of carbamates as a mechanism for CO2 detection and 
signalling will be reviewed in the following sections.  
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1.2 Carbamate bond formation and properties   
Carbamate bonds form in biological systems when the nitrogen atom of a neutral amine 
makes a nucleophilic attack upon the carbon atom of a carbon dioxide molecule (Figure 
1.2.1) (Lorimer, 1983), leading to the carbon dioxide molecule becoming attached to the 
nitrogen. The reaction is readily reversible, meaning that the carbamate is labile and easily 
dissociates, a property which is necessary to allow regulation of any downstream effects 
within a system. Whether a carbamate will form depends upon both the pKa value of the 
amine group of the amino acid. The pKa value of an amine group of an amino acid can be 
defined as the pH at which half of the amine group is ionised. At a physiological pH of 7.4 
the majority of amino acids have amine groups with pKa values of 9.0 or above (Vcelakova 
et al., 2004), and thus the vast majority of amine groups will be positively charged and 
unable to form a carbamate. However exceptions can occur due to the fact that the pKa 
value of an amino acid can be influenced by its local environment (Kleinboelting et al., 
2014). For example the specific environment of an amino acid within the 3D structure of a 
protein may lower its pKa value thus allowing carbamate formation to occur. Lysine and 
arginine amino acids both have amine side chains and so are capable of forming a 
carbamate. Of these lysine is the most likely candidate due to the lower pKa value of the 
amine group in an environment at physiological pH. In addition N-terminal amino acids have 
free alpha amino groups which tend to have lower pKa values, meaning they could also be 
capable of forming a carbamate (Miller et al., 2014, Myers and Nelson, 1990) 
In addition to pH, carbamate formation is also influenced by the amount of CO2 present 
within a system; with more CO2 available it may be expected that the amount of 
Figure 1.2.1: Mechanism of amine carbamylation by CO2 
A neutral amine on an amino acid such as phenylalanine has a lone pair of 
electrons, enabling it to make a nucleophilic attack on the less electron 
dense carbon of the CO2 molecule. This results in the carbon dioxide 
becoming bonded to the nitrogen atom of the amine group. 
 
11 
 
carbamylation increases. However if the concentration of CO2 is increased a decrease in 
pH will occur, depleting the supply of uncharged amine groups. This may explain why the 
photosynthetic enzyme Rubisco, which requires carbamylation in order to become 
activated, is less carbamylated and therefore less active under high CO2 concentrations 
(Roh, 1996).  Similarly the availability of molecular CO2 is also regulated by pH; at the higher 
pH values favourable for carbamate formation the CO2 equilibrium as shown in figure 1 will 
be shifted to the right, so less CO2 will be in the molecular form and more will be present as 
HCO3-. Therefore carbamate formation in a biological system relies upon a balance 
between CO2 and pH, though it has been shown that lowering pH by a slight amount 
decreases carbamate formation more significantly than reducing the concentration of CO2. 
(Gros et al., 1976).   
The ability of the environment to regulate carbamate formation and the reversibility of the 
reaction therefore mean the modification is ideally suited to allow regulation of protein 
function by CO2 within biological organisms. This has shown to be the case in several 
proteins, examples of which shall be discussed in the following sections.  
 
1.3 Carbamates with structural and functional roles 
Carbamylation is known to be an important protein modification (Meigh, 2015). Discussed 
here are several examples of proteins for which the formation of a carbamate has proven 
to be essential to their function.  It will be shown that the carbamate modifications are 
necessary for a variety of different functions, from altering the structure of a protein to allow 
it to become activated for a particular purpose, to being directly involved as a substrate in 
reaction mechanisms.  
1.3.1 Haemoglobin: formation of an N terminal carbamate for CO2 transportation 
Haemoglobin is a globular protein consisting of two alpha and two beta amino acid chains. 
It has long been known that haemoglobin is able to bind to and transport carbon dioxide as 
well as oxygen, with each influencing the binding affinity of the other (Bohr, 1904). In well 
oxygenated environments the structure of haemoglobin allows it to preferentially bind 
oxygen tightly. However as the concentration of CO2 increases, for example in respiring 
muscle tissue, the pH becomes more acidic due to the formation of carbonic acid. This leads 
to a lysine residue in the haemoglobin alpha subunit becoming protonated and allowing it 
to interact with the carboxylic acid of histidine 146 in the beta subunit. This in turn can then 
form a salt bridge with aspartate 94 in the beta subunit. The haemoglobin undergoes a 
conformational change in structure, meaning that oxygen is less tightly bound and once 
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released is not able to bind easily again. The result is that oxygen is released into tissue 
where it is most required (Hsia, 1998).  
It has long been established that haemoglobin was also capable of binding and transporting 
CO2. Henriques was the first to provide evidence suggesting that carbon dioxide binds to 
haemoglobin via the formation of a carbamate (Henriques, 1928). This was established 
simply by measuring the rate at which carbon dioxide was liberated from a mixture of 
haemoglobin and inorganic carbon (CO2 and HCO3-) during shaking at a physiological pH 
(Henriques, 1928). Henriques found that carbon dioxide was at first produced rapidly, and 
then in a much slower second phase. He suggested this pattern was due to a formation of 
reversible carbamates which rapidly dissociated from haemoglobin upon shaking, followed 
by slow production of carbon dioxide from the reduction of HCO3- to CO2 and H2O.  
At first Henrique’s interpretation of his results was treated with controversy. At the time of 
his experiment the enzyme carbonic anhydrase had not yet been discovered, and 
Henriques had unknowingly inhibited it in his experiments, meaning not everyone was able 
to reproduce his results. Those who did  achieve similar results to Henriques discounted 
the idea of a carbamates and (wrongly) attributed the first rapid production of CO2 to a 
‘catalytic action’ of haemoglobin itself (Slyke, 1930, Dirken and Mook, 1930).  It was not 
until the discovery of carbonic anhydrase and the subsequent important experiments by 
Meldrum and Roughton, showing that only when carbonic anhydrase was inhibited could 
Henriques results be consistently reproduced (Meldrum and Roughton, 1933), that the 
carbamate hypothesis started to gain more ground.  
The first decisive evidence that the CO2 was forming carbamates on the alpha amino groups 
of the haemoglobin chains did not appear until the 1960’s (Kilmartin and Rossi-Bernardi, 
1969). This was achieved by modifying the alpha-amino groups of haemoglobin by reacting 
them with cyanate, making them unable to form carbamates. Using titration and CO2 binding 
studies, they showed that blocking the N-terminals of both the alpha and beta chains of 
haemoglobin prevented all CO2 binding. Later experiments on haemoglobin provided further 
proof of carbamate formation, with X-ray studies confirming the site of the modification to 
be the N-terminal Valine residue (Arnone, 1974). In addition further studies on the alpha 
and beta chains found that in deoxyhaemoglobin both have similar binding affinities for CO2 
(Perrella et al., 1975). However there are still no detailed structures showing haemoglobin 
with a carbamate modification.  
Carbamate formation on haemoglobin is important both in terms of CO2 transport and in 
altering the confirmation of the molecule.  Initial studies used precipitation experiments to 
estimate the amount of carbamylated haemoglobin formed in mammalian blood (Ferguson, 
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1936, Ferguson and Roughton, 1934, Stadie, 1935). Though these studies provided further 
evidence of carbamate formation they were not very accurate in quantifying it, estimating 
that one third to three quarters of the CO2 present in reduced blood is transported via 
carbamate formation. It is probable that an overly high pH led to their large overestimates, 
as carbamate formation increases greatly with an increase in pH as more of the amine side 
chains become neutral in charge. We now know that the figure of CO2 transport by 
carbamate is closer to between 5-10% and in highly active respiratory tissue will actually 
drop to lower than this. This is due to the fact that the pH of the blood drops so low that the 
N terminal valines of the haemoglobin molecule become ionised and are unable to form 
carbamates. In addition to helping transport CO2 the carbamate modification is also 
commonly thought to help stabilise the deoxygenated structure meaning more O2 is 
offloaded to respiring tissues (Berg JM, 2002).  
The ability of haemoglobin to form a functional carbamate is a clear example of how the 
environment of an amino acid can change its pKa value. The pKa value of the N terminal 
valine in haemoglobin is unusually low at around 7.0, with the beta chain valine being slightly 
lower than the alpha chain (Kaplan et al., 1982).  Therefore even when more protons are 
present during acidification of the blood by CO2, haemoglobin is still able to form a 
carbamate bond to transport CO2.  
1.3.2 Rubisco: carbamylation to facilitate metal ion recruitment 
 Rubisco is a crucial enzyme found in aerobic organisms such as plants and cyanobacteria, 
and is responsible for the conversion of CO2 into ribulose 1-5 bisphosphate, which can then 
be used in the synthesis of biomass (Notni et al., 2008). In order for Rubisco to be activated  
CO2 must first bind to the protein, facilitating the binding of a magnesium ion to the active 
site of the protein (Park et al., 2008). It has been shown that the CO2 binds to Rubisco via 
the formation of a carbamate. This was shown early on by O’Leary et al who used 13C NMR 
spectroscopy and 13CO2 to identify that a carbamates was formed on an amino group of the 
enzyme (O'Leary M et al., 1979). However by using this method it was not possible to 
determine which residue the carbamate formed upon. In addition the alkaline pH used for 
the study meant that the carbamate could have been formed artificially under non 
physiological experimental conditions.  
A different approach was taken by Lorimer et al, who developed a method to stabilise the 
specific carbamate onto the Rubisco protein, allowing the carbamylated peptide fragment 
to be identified using various types of chromatography (Lorimer and Miziorko, 1980). This 
was performed by supplying radioactively labelled 14CO2 to Rubisco and stabilising the 
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resulting carbamate using carboxyarabinitol 1, 5-bisphosphate (CABP). Diazomethane was 
used to methylate the Rubisco-carbamate complex, and the extremely stable methyl bond 
meant that the carbamate was now trapped and analysis could proceed.  In this way they 
identified the carbamylated residue as lysine 201, found in the catalytic site of Rubisco 
(Lorimer and Miziorko, 1980).  
More recent studies have clearly shown the carbon dioxide molecule in the active site of 
Rubisco using protein crystallography, as shown in Figure 1.3.2.1 (Stec, 2012, Maeda et 
al., 2000). These studies have also helped reveal that once formed the carbamate both 
allows the recruitment of and is stabilised by a Mg2+ ion, as well as hydrogen bonding 
between other key residues in the active site (Maeda et al., 2000). Only once both the 
carbamate and the magnesium ion are present can Rubisco become an active enzyme. 
Therefore it can be seen that Rubisco is another protein where carbamylation is crucial to 
stabilise the active structure of the enzyme in order to allow it to function. 
Figure 1.3.2.1: Carbamate in active site of Rubisco 
The carbamylated Lys201 residue can be seen here in the pre-activation complex Rubisco 
from the red algae Galdieria sulphuraria, according to a recent crystal structure. The 
negatively charged carbamate allows recruitment and coordination of the magnesium ion. 
The interaction with the magnesium ion alongside hydrogen bonding to neighbouring 
residues also helps to stabilise the carbamate residue. Image from Stec, 2012 
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The fact that Rubisco is most active at pH 8.0 or more is a further example of how pH of the 
environment is critical to carbamate formation. In the presence of light the pH of the stroma 
becomes more alkaline, and this shows a corresponding increase in Rubisco carbamylation 
and hence activity of the enzyme (Heldt, 1979). It is important to note that carbonic 
anhydrases which are required to supply CO2 to the vicinity of the Rubisco are also most 
active at more alkaline pH’s (Igamberdiev, 2015), so there is more than one contributing 
factor to the increase in Rubisco activity.  However it is still apparent that in the case of 
Rubisco the stroma pH is regulating the activity of the enzyme through controlling the extent 
of carbamate formation.  
1.3.3  Connexin 26: structural changes independent of metal ion recruitment 
The proposed carbamylation of connexin 26 is an example of where a carbamate can 
interact with neighbouring residues to alter the structure of a protein, independently of 
interactions with metal ions. Meigh et al have recently shown that under constant pH 
connexin 26 (Cx26) hemichannels, which help control ventilation rates in mammals, are still 
able to respond to CO2 (Meigh et al., 2013). They hypothesised that this was due to the CO2 
directly binding to a lysine residue in one of the Cx26 residues via formation of a carbamate. 
A ‘carbamylation motif’ was identified as a sequence of amino acids including a K124 
residue that would accommodate a carbamate. This would then subsequently alter the 
structure of the connexion hemichannel by forming a salt bridge with a neighbouring 
arginine residue (Figure 1.3.3.1) causing the channel to open (Meigh et al., 2013).  
Mutational studies where the proposed carbamate forming K124 residue was changed to 
an alanine prevented the Cx26 channel from opening. In addition when the carbamylation 
motif was transferred to a non-CO2 responsive connexin, it gained the ability to respond to 
CO2 and opened. Finally these results were shown to occur even when pH remained 
constant, so was not due to changes in concentrations of H+.   
However this paper offered no structural data to prove that CO2 was forming a carbamate, 
though computational modelling suggested that this was likely the case.  As no attempt was 
made to distinguish between the CO2 and HCO3- present in the experiments, it was also 
possible that HCO3- could have been responsible for the changes rather than molecular 
CO2, though again this would not have fitted the proposed model. Therefore it has not yet 
been conclusively established that a carbamate is responsible for the response to CO2 in 
the connexin. 
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1.3.4  Class D β-Lactamases: examples of mechanistic carbamates  
A relatively recent discovery of protein carbamylation is that of the proteins belonging to 
Class D of the β-Lactamases. β-Lactamases are a type of enzyme found in many bacteria 
which are capable of hydrolysing the antibiotic β-Lactam, and are grouped into four classes 
based on molecular structure (Leonard et al., 2013). Classes A, C and D are all serine 
hydrolases, whilst class B is zinc dependent (Bush et al., 1995, Therrien and Levesque, 
2000). β-Lactamases pose a serious challenge to the use of β-Lactam antibiotics to treat 
diseases. Due to overuse of β-Lactams increasing numbers of bacteria are acquiring β-
Lactamases and therefore resistance to the antibiotic (Bush, 2013). The main approach to 
combat the presence of β-Lactamases has been to inhibit them, though as there are over 
1400 different β-Lactamase enzymes this is challenging (Leonard et al., 2013, Toussaint 
and Gallagher, 2015).  
A B 
Figure 1.3.3.1: Proposed site of carbamylation in connexin-26 
A) Crystal structure of Cx26 showing the site hypothesised to contain a carbamate. B) 
Magnification of site of carbamylation shown in dashed square. The K125 residue (red) 
is only a short distance from the R104 residue (grey). If the K125 residue was 
carbamylated it could potentially form a salt bridge to the R104 residue, activating the 
hemichannel. Images from Meigh et al, 2013 
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Class D β-Lactamases contain the prefix OXA in their nomenclature, due to their ability to 
hydrolyse oxacillin, a semi-synthetic penicillin (Leonard et al., 2013). In addition Class D β-
Lactamases can also confer resistance against other types of β-Lactam antibiotics that are 
commonly effective against other classes of β-Lactamases. These include cephalosporins, 
carbapenems, and combinations of β-Lactam coupled with β-Lactamase inhibitors (Afzal-
Shah et al., 2001, Paterson, 2006). Therefore it is particularly important to find new ways of 
inhibiting this class of enzymes.  
It was first discovered that members of Class D β-Lactamases required a carbamate to 
function from initial crystal structures of the OXA10 enzyme from Pseudomonas aeruginosa. 
(Maveyraud et al., 2000, Golemi et al., 2001). Initially OXA-10 was shown to form a dimer 
and it was found that the K70 residues of each of the monomers possessed a region of 
electron density strongly suggestive of a carbamate (Maveyraud et al., 2000). The K70 
residues were both found in the active sites of the enzyme, which are located on the same 
face of the protein dimer. Class D β-Lactamases hydrolyse β-Lactam via a serine acylation 
mechanism, whereby the substrate undergoes acylation by an active site serine residue in 
the first step of the catalytic process (Figure 1.3.4.1).  It was suggested by Maveyraud et al 
that the carbamate hydrogen bonded to and was stabilised by the Ser-67 residue which it 
then activated to allow acylation to proceed (Maveyraud et al., 2000). The carbamate was 
also proposed to participate in the deacylation of the substrate, by activating the hydrolytic 
water molecule (Figure 1.3.4.1) 
The active site structure showed the carbamate hydrogen bonded to both aTrp-154 nitrogen 
atom and a water molecule, further stabilising it and allowing it to participate in the hydrolysis 
mechanism. As further evidence that a carbamate was needed to form an active enzyme 
the group placed the decarbamylated protein in degassed (CO2 free) buffer and found that 
it had no activity. When bicarbonate was added to increase the pH above pH 7.0 then the 
enzyme became active again (Maveyraud et al., 2000). However this basic experiment, 
though suggestive of a functional carbamate, did not take into account the possible effect 
of the change in pH altering the activity. 
Experiments by Golemi et al provided additional evidence for the essential function of the 
carbamate in both the acylation and deacylation of Ser-67, by acting as a general base. It 
was shown that in addition to the stabilising interactions shown by Maveyraud et al, the 
amino acids in the immediate vicinity of the carbamate forming K70 caused a hydrophobic 
environment which would facilitate carbamate formation at a physiological pH (Golemi et 
al., 2001). This hydrophobicity of the active site region is much greater than in the other 
serine hydrolase classes A and B of β-Lactamases, which do not form carbamates (Leonard 
et al., 2013). The enzyme activity experiments were also repeated more thoroughly, where  
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increasing activation of OXA-10 was shown with increasing amounts of bicarbonate and 
correspondingly more carbamate formation, this time controlling for pH effects (Golemi et 
al., 2001). 13C NMR was also used to prove the location of the carbamate, and mutations 
of the K70 residue to Ala produced a completely inactive protein. Therefore overall there 
was a large amount of data showing that a carbamate was forming and influencing the 
activity of the enzyme. The authors also found that the extent of carbamylation was 
dependent on pH with full carbamylation at pH 8.0, none at pH 6.0, and intermediate levels 
at the pH values in between. As we have already seen how pH affects protonation status 
i ii 
iii iv 
Figure 1.3.4.1: Role of the carbamate in the catalytic mechanism of Class D              
β-lactamases 
A proposed role for the carbamate on K70 of Class D β-lactamases is to act as a general 
base for the H+ ion belonging to the neighbouring S67 residue, activating the first step of 
the reaction (i). This causes acylation of the substrate by S67 (ii) resulting in transfer of 
electrons from the substrate to S115 and onto the carbamate, deprotonating the carboxyl 
group and activating a water molecule in the active site (iii) The water molecule then 
hydrolyses the ester linkage of the β-lactam, releasing the inactivated substrate from the 
enzyme (iv). Mechanism published by Leonard et al., 2013.  
 
(Leonard et al., 2013) 
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and hence carbamylation this is not a surprise; as the pKa value of K70 was found to be just 
5.8 then at physiological pH’s it should be fully carbamylated (Golemi et al., 2001).  
The combination of the results from these important studies conclusively established for the 
first time that carbamylation is a critical mechanism for the activation of the OXA-10 β-
Lactamase. Since these initial findings several Class D β-Lactamases have been shown to 
form a carbamate necessary for the acylation of the serine residue to occur, including OXA-
1, OXA-24, OXA-46 and OXA-48 (Leonard et al., 2008, Che et al., 2014, Docquier et al., 
2010, Docquier et al., 2009). Some of these β-Lactamases are monomeric and some are 
dimeric. However the hydrophobic active site containing the key residues needed to form a 
carbamate is conserved among each of the proteins. In contrast to the majority of studies 
on haemoglobin and Rubisco all of the Class D β-Lactamases were found to bind 
carbamates from analysing the crystal structures of the proteins. This was likely because 
having shown this was an effective method for analysing OXA-10 it was then repeated for 
other members of the class.  
Despite all being able to form a carbamate not all the Class D β-Lactamases catalyse the 
hydrolysis of their substrate by the same mechanisms, highlighting the importance of other 
components of the active site in influencing the functions of carbamates.  OXA-1 and OXA-
24 are both monomeric proteins which form carbamates at K70 and K84 respectively, but 
their ability to do so differs (Che et al., 2014). OXA-10 is carbamylated more easily and 
decarbamylated with more difficulty than OXA-1 (Che et al., 2014). It has been shown that 
this is due to a water molecule that is found in the active sites of both OXA-1 and OXA-10, 
but not OXA-24, which lowers the energy needed for carbamylation by helping to position it 
correctly for attack by CO2 also stabilising it (Li et al., 2005, Che et al., 2014).  This has 
implications on the resistance of these β-Lactamases to inhibitors, by influencing their 
reaction mechanisms when inactivating their substrates. Whilst the penem 1 inhibitor can 
decarboxylate OXA-1 it is unable to do so to OXA-24 unless conditions where there is a 
great excess of the antibiotic (Che et al., 2014). Therefore in order to understand how a 
carbamate influences the structure or reaction mechanism of a protein it is important to take 
into account how it interacts with the amino acids and molecules surrounding it. In the case 
of Class D β-Lactamases this is an important aspect of inhibitor design. 
Class D β-Lactamases are unique among the other examples of protein carbamylation 
which have been discussed, in that they form carbamates which participate in a reaction 
mechanism of an enzyme, rather than just altering the structure of the protein to allow it to 
function. It would be interesting to see if more protein carbamates with this type of 
mechanistic function are discovered in future.  
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1.4  The need to further understand protein carbamylation 
There is a clear need for organisms to be able to detect and respond to CO2, and it is not 
surprising that carbamate modifications play important roles in the functions of the proteins 
discussed in the previous section. What is more unexpected is that given the prevalence of 
CO2 in most biological systems, relatively few proteins have been shown to be 
carbamylated. This could be due to a number of reasons. Firstly, research on carbon dioxide 
detection and signalling has often focused on the response to changes in pH caused by 
CO2 rather than any direct interactions with molecular CO2, as is the case with carbamate 
formation. There is comparatively less material published where the mechanisms by which 
carbon dioxide might modify proteins in a biologically relevant manner have been explored.  
Secondly it is hard to investigate protein carbamate bonds thoroughly due to their labile 
nature (Lorimer, 1983). Unless it is stabilised by interactions within the protein or with 
ligands the carbamate bond itself is too unstable to withstand the rigours of analytical 
techniques such as Mass spectrometry and NMR. This means that it is hard to gain 
information about the precise positions and interactions of protein carbamate bonds.  
Therefore it would be highly advantageous to be able to develop a method for rapid analysis 
of proteins to determine if they form a carbamate modification, without the risk of the 
carbamate disappearing during the analysis process.  This would allow a greater 
understanding of the extent of physiological protein carbamylation, and of the role that 
carbamates play in CO2 detection and signalling. It would also allow us to better understand 
the carbamate modification itself, and how likely it is to occur on different amino acids. For 
example, excluding N terminus carbamates, all the proteins discussed in the previous 
section were shown to form a functional carbamate do so on a lysine residue, despite 
arginine also having an amine side chain that could bind a carbamate. This is likely because 
of the lower pKa value of lysine making it more likely to form a carbamate at physiological 
pH values. It would be interesting to see if any functional carbamates do form at arginine 
residues of proteins, and a rapid and accurate method of investigating carbamylation could 
ensure this.  
An additional point of interest is that in almost all cases of carbamate formation discovered 
the carbamate has been found in the active site of an enzyme, often coordinating a metal 
ion (Stec, 2012, Jabri et al., 1995, Benning et al., 1995). In these cases the carbamate tends 
to play either a structural role in activating the enzyme or in some cases directly participates 
in the functional mechanism. This is to be expected as the anionic charge that a carbamate 
creates makes it ideal for interactions with metal ions or hydrogen bonding to other residues. 
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What is more surprising is that more carbamates have not been discovered bound at the N 
terminal residues of proteins. Only in haemoglobin has this been shown to occur, where it 
plays a role in both transport of CO2 and in stabilising the protein’s deoxygenated structure. 
Given that all proteins contain an N terminal residue with a free amine group it could be 
expected that a least a few proteins would have an N terminus with a sufficient pKa value to 
allow carbamate formation. Perhaps as these hypothetical carbamates may not directly 
participate in the main known functions of the proteins as occurs in many enzyme 
carbamates, they have simply not been discovered. Whether they exist and if so have an 
important functional role or not are both questions that could be answered by further 
research into carbamate modifications.   
 
1.5  Methods for stable trapping of carbamate modifications  
In the past various methods have been used to show that a carbamate is bound to a protein. 
Most of the techniques have been discussed already in regard to the studies carried out on 
haemoglobin and Rubisco. Labelling of carbamates using radioactive carbon dioxide and 
identifying their presence by an NMR shift were originally commonly used methods(O'Leary 
M et al., 1979), however the conditions used for these experiments are highly artificial in 
order to stop the carbamate dissociating, and so not representative of a physiological 
environment. In addition little information can be gathered this way about the precise 
location of the carbamate on the protein. Methods using crystallography (Stec, 2012) give 
detailed information about the carbamate’s location and its interaction with other proteins, 
but again conditions used are often artificial and the process can be lengthy. In addition 
neither of these methods alone are suitable to use for screening to detect carbamate 
modification, each is used to prove or disprove the concept that a carbamate is already 
present.  
 
The ideal method for identifying a carbamate would be to first stabilise it on the protein 
under physiological conditions to prevent artificial results. This would then facilitate analysis 
using techniques such as Mass Spectrometry and NMR. A method of stabilising a 
carbamate  was first used by Lorimer et al who used diazomethane to successfully 
methylate a carbamate on Rubisco, allowing it to be rigorously analysed (Lorimer and 
Miziorko, 1980). A more recent study on trapping of carbamic acid species also showed 
that diazomethane was capable of methylating carbamates to create highly stable 
derivatives (Ito and Ushitora, 2006). However there are downsides to the use of 
diazomethane, chiefly that it is very hazardous to work with due to the risk of explosions 
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from its extreme reactivity and also because it is very toxic (Moore, 1973). Additionally it 
can only be used in organic solvents so is not ideal for studying proteins in their native 
conditions, and could also result in protein denaturation which could cause release of any 
carbamates before they can be trapped. 
An alternative alkylating reagent that has the been shown to be able to ethylate rather than 
methylate carbamates is Triethyloxonium tetrafluoroborate (TEO), also known as 
Meerwein’s Reagent (Chen and Benoiton, 1977).  TEO is less toxic and less reactive than 
diazomethane under experimental conditions, making it a safer reagent to use to stabilise 
carbamates. The use of TEO to investigate properties of proteins is not a new one, however 
the focus of previous studies has been on carboxyl groups rather than carbamates, with 
TEO being used to ethylate carboxyl groups of insulin, trypsin, and lysozyme (Levy, 1973, 
Parsons et al., 1969, Ben Avraham and Shalitin, 1985). The related trimethyloxonium 
tetrafluoroborate has also been used to ethylate carboxyl groups belonging to pepsin 
(Paterson and Knowles, 1972).  
 In all these studies the purpose of the ethylation was to subject one or more carboxyl 
groups of the proteins to a protective modification, in order to prevent any normal functions 
they may have within the protein. In this way the contribution of the carboxyl groups to the 
proteins structure and/or functional activity could be assessed. Interestingly despite the 
additional ethyl groups altering the overall charge status of the protein, all of the proteins 
were found to retain at least some extent of their functions, although their specific activity 
was often much reduced. For example trypsin ethylated at its binding site lost 80% of its 
ability to cleave proteins specifically at the carbonyls of lysine and arginine residues, 
however it was still able to cleave non-specifically at a reduced rate, so was still at least a 
partly functional protein (Ben Avraham and Shalitin, 1985). This is important as it means 
that the ethyl modifications do not necessarily mean that a protein will be completely 
denatured, which could be a useful feature for assessing the functional properties of a 
protein with ethylated carbamates. However further investigation would be needed to 
determine whether the situation would be the same in carbamate ethylation experiments as 
in carboxyl ethylation experiments.  The ability of the protein to retain its function would also 
be dependent on the extent of the ethylation which would also have to be determines 
experimentally.  
Investigations into the use of TEO as a trapping agent for carbamates have been ongoing 
at Durham University and have shown that it is capable of stabilising carbamates onto amino 
acids, which can then be analysed by Mass spectrometry (Vicki Linthwaite, unpublished 
research). The mechanism of carbamate ethylation by TEO is shown in Figure 1.5.1. 
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The implications of using TEO to trap carbamates are far reaching. The method is rapid and 
can be used to trap carbamates that have already formed on proteins, without having to 
alter the pH of the protein or expose it to a non-aqueous potentially denaturing environment. 
This is not to say that TEO will not denature a protein eventually, the extensive ethylations 
of not just carbamates but all free carboxylic acid and amine group mean that the protein 
becomes hydrophobic and forms a non-functional precipitate (unpublished research). 
However by this point all carbamates should be trapped and so the protein structure and 
function is no longer needed to be intact. Furthermore, if necessary it may be possible to 
experimentally determine a concentration of TEO that will trap carbamates without fully 
denaturing the protein, as discussed earlier (Ben Avraham and Shalitin, 1985).  
Stable trapping of carbamates in this way means that instead of having to painstakingly 
analyse one protein at a time, as has been undertaken for haemoglobin and Rubisco, 
theoretically many proteins can be exposed to the trapping agent at once, for example in 
an extract from a cell lysate. Any carbamates will then be trapped and the proteins can be 
analysed simultaneously using proteomic mass spectrometry techniques, allowing those 
containing carbamates to be identified. Therefore this would be a much faster approach to 
identifying proteins whose functioning relies on the formation of a carbamate by screening, 
opening up a potentially new and large field of carbamate biology.  
 
Figure 1.5.1: Trapping of a carbamylated amine group by TEO 
The lone pair of electrons of a neutral amine (shown here on phenylalanine) makes a 
nucleophilic attack upon a CO2 molecule, forming a negatively charged carbamate.  The 
carbamate group then makes a nucleophilic attack upon a TEO molecule, causing an 
ethyl group to become stably bound to the carbamate. Therefore the carbamate is now 
trapped onto the phenylalanine as it is no longer able to dissociate.  
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1.6  Aims of this project  
This first main aim of this project was to develop a method to trap carbamate modifications 
onto proteins using the ethylating chemical reagent Triethyloxonium tetrafluoroborate 
(TEO).  To do this it first had to be confirmed that TEO could trap carbamates on an amino 
acid. After this was achieved the trapping method could be adapted for use on proteins, 
using haemoglobin as a control protein for method development as it is known to form a 
carbamate. At this stage a methodology for analysis of the sample using mass spectrometry 
was also developed, in addition to a way of analysing the results.   
The second main aim was to use the method developed to test proteins unknown to form a 
carbamate. Adenylyl cyclases were chosen for this, as will be explained later. In addition to 
mass spectrometry the trapping method was also adapted to use in radioactivity 
experiments.  
The ultimate aim of this project is to contribute towards the development of a method to 
screen many proteins in a cell lysate for carbamate modifications simultaneously, using 
mass spectrometry proteomics. This will be a valuable tool in enabling us to better 
understand the extent and the roles of protein carbamylation in physiology. Although this 
final aim was beyond the scope of this project, the experiments and results detailed in this 
thesis will form a key component of its progress. 
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2.1  Trapping and analysis of carbamate formation  
2.1.1 Trapping carbamates on phenylalanine 
20 mg of phenylalanine was dissolved in 3 ml deionized H2O. 20 mM NaHCO3 was added 
to provide CO2 at a physiologically relevant concentration. A total of 400 mg of TEO was 
added in 100 mg quantities. Each 100 mg of solid TEO was dissolved in 250 µl of H2O and 
immediately added to the reaction. The final TEO concentration was 0.97 mM. The mixture 
was incubated at 25oC for one hour, during which pH was maintained as close to 7.4 as 
possible using a pH stat (section 2.1.2). After one hour the mixture was placed in a round 
bottomed flask and frozen rapidly using an acetone ice bath. A freeze dryer was used to 
lyophilise the sample. The powder was then stored at -20oC until analysis by ESI-MS. 
2.1.2 Controlling pH using pH stat 
A Titralab 854 pH stat was used to maintain the correct pH throughout the trapping 
experiments. The STAT software was used to set the desired pH and other conditions, with 
pH 7.4 being used for all proteins except Rubisco. 1 M NaOH was used to adjust the pH. 
The time constant was set to 5.0 seconds, Gain to 0.1 and maximum addition speed to 5 
ml/minute with stirring at 250 rpm. A water bath was used to maintain temperature at 25oC. 
Both the pH and the volume of NaOH added were recorded throughout the duration of the 
experiment. 
2.1.3 LC/ESI analysis of carbamylated phenylalanine 
After the trapping experiment (Section 2.1.1), 0.5 mg of lyophilized phenylalanine was 
transferred to a glass vial. 1 ml of methanol was used to dissolve the powder to give a 
concentration of 0.5 mg/ml. The sample was submitted for analysis by Electrospray 
Ionisation coupled to Liquid Chromatography (LC/ESI). The calculated m/z values of the 
potential carbamylated and ethylated species produced in the experiment were used to 
identify whether they were present in the analysed sample.  
2.1.4 Trapping carbamates on proteins for Mass Spectrometry analysis 
Trapping experiments were performed on haemoglobin, Rubisco, 7C1.2C2 mammalian AC 
and Rv1625c203-443 proteins. Haemoglobin and Rubisco were purchased as recombinant 
proteins. The 7C1 and 2C2 mammalian AC proteins and Rv1625c203-443 proteins were 
recombinantly expressed in Escherichia coli (Section 2.2). For all MALDI mass 
spectrometry experiments 1 mg of each protein was used, except during initial experiments 
when different quantities of haemoglobin was used for method optimisation. It has been 
previously shown that mixing the 7C1 and 2C2 subunits of the mammalian tmAC together 
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prior to an experiment forms a functional catalytic site (Townsend et al., 2009) therefore 
equal quantities of the two subunits were combined prior to the start of each experiment.  
For all experiments 1mg of the relevant protein was used in 3ml phosphate buffer, which 
was maintained at the physiological pH of the protein’s natural environment. This was pH 
7.4 for all proteins except Rubisco, which was pH 8.0. 20 mM NaHCO3 was added 
immediately prior to the start of the experiment to provide CO2 at a physiologically relevant 
concentration. Experiments were performed using both 12C and 13C labelled NaHCO3. A 
total of 280 mg of TEO was added in 70 mg quantities. Each 70 mg of solid TEO was 
dissolved in 250 µl of H2O and immediately added to the reaction. The end TEO 
concentration was 0.68 mM The mixture was incubated at 25oC for one hour during which 
pH was maintained as close to correct pH as possible using the pH stat (Section 2.1.2) After 
one hour the ethylated protein had precipitated out of solution. The whole mixture including 
the precipitate was dialysed overnight against 4 L of distilled H
2
O (1:1000 ratio of sample: 
dialysis buffer). After dialysis the sample was centrifuged to pellet the precipitated protein. 
The supernatant was concentrated using spin columns to a volume of 100 µl to concentrate 
any non-precipitated protein. The pellet of precipitated protein was then resuspended in the 
100 µl of concentrated supernatant, and the sample trypsin digested (Section 2.1.5). 
2.1.5 Trypsin digestion of proteins  
A 100 µl sample containing mostly precipitated protein from the trapping experiment 
(Section 2.1.4) was used for trypsin digestion. DTT was added to a concentration of 5 mM 
and the sample incubated at 50
o
C for 20 minutes. Ioadacetamide was then added to a 
concentration of 15 mM and the sample incubated at room temperature, in the dark, for 15 
minutes. 10 µl of Mass spectrometry grade Trypsin at a concentration of 0.2 mg/ml was 
added and the samples incubated shaking, overnight at 37oC. 
2.1.6 Analysis by Matrix Assisted Laser Desorption Ionisation (MALDI) and Tandem 
Mass Spectrometry (MS/MS)  
After trypsin digestion (Section 2.1.5) samples were centrifuged to pellet any remaining 
precipitated protein. The supernatants were passed through C18 ZipTip pipette tips to both 
remove unwanted salts and to concentrate the trypsin cleavage fragments. The ZipTip was 
equilibrated by wetting 2x in 10 µl Acetonitrile followed by 1x 10 µl 0.1% (v/v) TFA. The 
sample was added to the ZipTip by taking 10 µl of supernatant and pipetting up and down 
slowly 10 times, then repeating with another 10 µl supernatant. The ZipTip was then washed 
using 3x10 µl of 0.1% (v/v) TFA. The protein trypsin digest fragments were eluted by 
pipetting up and down slowly 3x using 5 µl of 30% (v/v) Acetonitrile, 0.1% (v/v) TFA. 1 µl of 
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each ZipTipped sample was spotted in triplicate onto a MALDI sample plate and mixed 
immediately with 1 µl of CHCA matrix and allowed to crystallise. The samples were 
analysed by MALDI/TOF. An Excel database was used to compare expected masses of 
carbamylated protein fragments to the fragment masses found in the sample using MALDI. 
Protein fragments that contained a carbamate as identified by MALDI were then analysed 
by MS/MS. The selected fragment was further fragmented using collision induced 
dissociation and the product ions separated by mass in a second mass spectrometer.  
2.1.7   14CO2 carbamylation assays 
Protein was dissolved or dialysed into 50 mM phosphate buffer, pH 7.4.  5 mg of protein 
was used in each trapping experiment, with the exception of Rubisco where 2.5 mg was 
used. 6.8 mg of NaHCO3 was dissolved in 1 ml of the phosphate buffer (final concentration 
20 mM) and added immediately prior to the start of the experiment to provide CO2 at a 
physiologically relevant concentration. 27 μCi of NaH14CO3 was added to the experiment 
and a 10 µl sample was immediately taken and added to a scintillation vial for scintillation 
counting. For scintillation counting 3 ml of Eco-Scint scintillation fluid was mixed with the 
sample and the 14C radioactivity measured using a scintillation counter. A total of 280 mg 
of TEO was added to the experiment in 70 mg quantities, with constant stirring. Each 70 mg 
of solid TEO was dissolved in 250 µl of H2O and immediately added to the reaction. The 
end TEO concentration was 0.68 mM. The pH was constantly monitored for 15 minutes 
from addition of the first amount of TEO using a pH probe and maintained at approximately 
pH 7.4 by manually adding small volumes of dilute NaOH. For Rubisco pH was maintained 
at a physiological pH of pH 8.0. After 15 minutes the pH had stabilised and the pH was no 
longer adjusted. The experiment was left for one hour after which time all TEO was 
hypothesised to have been hydrolysed. The mixture was centrifuged for 25 minutes at 4000 
g to pellet the precipitated protein. The pellet was then washed by resuspending in 1ml of 
50 mM phosphate buffer, pH 4.0, and centrifuging again for 2 minutes to pellet the 
precipitate. The wash step was repeated 2x then the pellet was resuspended in 500 µl of 
H2O. The suspension was transferred to a scintillation vial and mixed with 3 ml of scintillation 
fluid, and then 14C radioactivity measured using a scintillation counter. 
Control experiments were performed using no TEO. These experiments were carried out in 
the same way but 1 ml of water was added to the mixture instead of 4x 250 µl of TEO. After 
an hour 8 ml of ice cold acetone was added to the protein solution, which was vortexed then 
left for 20 minutes at -20oC to ensure all protein had precipitated. The pellets were then 
centrifuged and washed in acidic buffer as described above, and the 14C radioactivity 
counted.  
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Additional controls were performed using no radioactivity. These experiments were carried 
out in an identical way to the main experiments but no NaH14CO3 was added at the start of 
the experiment.  
 
2.2  Protein expression and purification 
2.2.1  Preparation of competent cells 
E. coli cells were taken from a glycerol stock maintained at -80oC and grown in 5 ml of LB 
media overnight at 37oC, shaking at 250 rpm. For strains containing antibiotic resistance to 
ampiciillin and/or kanamycin the LB media contained the antibiotics at a concentration of 
100 μg/ml and 50 μg/ml respectively. The overnight culture was diluted 1:100 using fresh 
LB media to a total volume of 10 ml. The culture was incubated at 37oC with shaking at 250 
rpm until it reached an OD600 of 0.4. The cells were then harvested by centrifugation at 2700 
g for 10 minutes and the supernatant removed. The pellet was resuspended in 5 ml of ice 
cold 20 mM CaCl2, 80 mMgCl2 by gentle pipetting. The cells were centrifuged again at 4oC 
for 10 minutes, 2700 rpm and the supernatant removed. The pellet was resuspended in 5 
ml of ice cold 100 mM CaCl2 by gentle pipetting. The cells were centrifuged for a final time 
at 4oC for 10 minutes, 2700 g and the supernatant removed. The pellet was resuspended 
in 0.5 ml of ice cold 100 mM CaCl2, containing 15% (v/v) glycerol. The cells were 
immediately aliquoted into 50 µl aliquots and stored at -80oC for future use.  
2.2.2  Isolation of plasmid DNA  
Plasmid DNA was isolated using the Qiagen mini prep kit according to the manufacturer’s 
instructions. E. coli were grown overnight from glycerol stocks at 30oC with shaking at 
200rpm in 5 ml LB containing appropriate antibiotics. The culture was harvested by 
centrifugation at 5,445 g for 5 minutes at room temperature and the supernatant removed. 
DNA was then extracted from the bacterial pellet using the ThermoFisher Scientific GeneJet 
Mini-prep kit. All of the following steps were carried out at room temperature, using a 
benchtop microcentrifuge at 1200rpm or centrifugations. The bacterial pellet was 
resuspended in 250 μl of Resuspension Solution containing RNase A, and transferred to a 
microcentrifuge tube. 250 μl of Lysis Solution was added and the tube inverted four times 
to mix. 350 μl of Neutralisation Solution was added and the tube inverted four times to mix. 
The mixture was centrifuged for five minutes to pellet debris. The supernatant was 
transferred to a GeneJET spin column. The spin column was centrifuged for 1 minute and 
the flow-through was discarded. 500 µl of wash solution was added to the spin column, the 
column was centrifuged at for 1 min and the flow-through was discarded. The wash step 
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was repeated using 500 μl of wash solution and the flow-through discarded. The spin 
column was centrifuged for an additional 1 minute to remove residual wash solution. The 
spin column was transferred to a clean 1.5 ml microcentrifuge tube. 50 μL of elution buffer 
was added to the centre of the resin and left to incubate for 2 minutes. The spin column was 
then centrifuged for 2 minutes to elute the DNA. The elution step was repeated using 50 µl 
of deionised H2O. DNA concentration and purity was measured at 260 nm using a Nanodrop 
2000 (Section 2.2.7) Purified plasmid DNA was stored at -20oC until needed.  
 
2.2.3 Transformation of plasmid DNA into competent cells 
1 μl of plasmid DNA corresponding to approximately 20ng of DNA (Section 2.2.2) was 
added to 50 μl of competent E. coli (Section 2.2.1), and the mixture incubated on ice for 20 
minutes. The cells were heat shocked for 30 seconds at 42oC, then placed on ice again for 
2 minutes. 450 µl of antibiotic free LB warmed to 30oC was added to the cells, which were 
then incubated for 1 hour at 30oC, shaking at 200rpm. After an hour ~200µl of the E. coli 
were spread on an agar plate containing appropriate antibiotics and incubated overnight at 
30oC to allow colonies to grow. Plates could be stored for up to a week at 4oC, until a colony 
was needed.  
2.2.4 Expression and Purification of Rv1625c204-443 wild type and mutant proteins 
DNA was isolated from E. coli BL21 (DE3) containing the pQE30-Rv1625c204-443wt plasmid 
(Guo et al., 2001) and E. coli M15 (DE3) containing the Rv1625c204-443 mutant plasmids 
(Section 2.2.2). The DNA was transformed into competent M15 (DE3) cells (Section 2.2.3). 
100 µg/mL ampicillin and 50 µg/mL kanamycin were added to the LB agar during selection 
for antibiotic resistance. One of the colonies produced after transformation was removed 
from the agar plate and transferred to 150 mL LB containing 100 µg/mL ampicillin and 50 
µg/mL kanamycin. The bacteria were incubated overnight at 30 C, 200 rpm. 10 ml 
quantities of the overnight culture were added to 12 x 1 L LB, each in 2.5 L baffled flasks 
containing 100 µg/mL ampicillin and 50 µg/mL kanamycin. The cultures were grown at 
30C, 140 rpm to O.D.600 = 0.6. Rv1625c204-443 protein production was induced with 45 µM 
isopropyl--D-thiogalactopyranoside (IPTG) and incubated at 30C for 3 hours. The culture 
was harvested by centrifugation at 4,000 g for 40 minutes at 4C using a Beckman JLA 
8.1000 rotor. The supernatants were removed and the bacterial pellets washed and 
resuspended in 20 ml wash buffer per 2 L culture (50 mM Tris-HCl pH 8.5, 1 mM EDTA). 
The cells were centrifuged at 5,445 g for 30 min at 4 C using a Beckmann Avanti 30 
centrifuge, then supernatants removed. The bacterial pellets were stored overnight at -
80C. Pellets were defrosted rapidly in a 37C water bath, with continual agitation to allow 
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them to remain cool, then kept on ice for the rest of the procedure. The pellets were 
resuspended in 10 mL of cell lysis buffer per original 1 L culture (50 mM Tris-HCl pH 8.5, 
300 mM NaCl, 10 mM 1-thioglycerol and 2 mM MgCl2). The cells were lysed by sonication 
for 2x 90 second cycles at 4C. Cell debris was removed by centrifugation at 20,000 g for 
45 minutes at 4C, using a Beckmann Avanti 30 centrifuge. 0.5 mL of nickel-nitrilotriacetic 
acid (Ni-NTA) slurry per original 1 L culture was added to the supernatant and the mixture 
was incubated for 3 h at 4 C. The mixture was centrifuged at 400 g for 1 min and the slurry 
poured into a 12 ml Polyprep column attached to a peristaltic pump. The columns were 
washed at a flow rate of 1 ml/min with 10x bed volume wash buffer A (50 mM Tris-HCl pH 
8.5, 10 mM 1-thioglycerol, 2 mM MgCl2, 400 mM NaCl and 5 mM imidazole), 10x bed 
volume wash buffer B (wash buffer A + 15 mM imidazole), 10x bed volume wash buffer C 
(wash buffer B + 10 mM NaCl). The last 1ml of each wash step was saved for analysis by 
SDS-PAGE. The pump was removed and the protein was eluted in 1ml fractions using 
elution buffer (wash buffer C + 150 mM imidazole). Elution fractions were collected until the 
concentration dropped below ~0.2mg/ml, with the nanodrop being used to measure protein 
concentration (Section 2.2.7). Protein MW and quality was established using SDS-PAGE 
analysis (Section 2.2.8). 20% (v/v) glycerol was added to all eluates which were frozen at -
80oC for storage. 
 
2.2.5 Expression and Purification of mammalian trans-membrane adenylyl cyclase 
(tmAC) 7C1a domain 
DNA was isolated from E. coli Tuner (DE3) containing the pProEx-HAH6-7C1a263-476 
plasmid (Section 3.2.2). The DNA was transformed into competent Tuner (DE3) cells 
(Section 3.2.3). 100 µg/mL ampicillin was added to the LB agar during selection for antibiotic 
resistance. One of the colonies produced after transformation was removed from the agar 
plate and transferred to 150 mL LB containing 100 µg/mL ampicillin. The bacteria were 
incubated overnight at 37C, 200 rpm. 10 ml quantities of the overnight culture were added 
to 12 x 1 L LB, each in 2.5 L baffled flasks containing 100 µg/mL ampicillin. The cultures 
were grown at 37C, 140 rpm to O.D.600 = 0.7.  tmAC-7C1a protein production was induced 
with 30 µM isopropyl--D-thiogalactopyranoside (IPTG) and the culture incubated at 20C, 
140 rpm overnight for a total time of ~17 hours. The culture was harvested by centrifugation 
at 4,000 g for 40 minutes at 4 C using a Beckman JLA 8.1000 rotor. The supernatant was 
removed and the bacterial pellets washed and resuspended in 20ml wash buffer per 2L 
culture (50 mM Tris-HCl pH 8.5, 1 mM EDTA). The cells were centrifuged at 5,445 g for 30 
minutes at 4C using a Beckmann Avanti 30 centrifuge, then supernatants removed. The 
bacterial pellets were stored overnight at -80 C. Pellets were defrosted rapidly in a 37C, 
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with continual agitation to allow them to remain cool, then kept on ice for the rest of the 
procedure. The pellets were resuspended in 10 mL of cell lysis buffer per original 1 L culture 
(50 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 mM imidazole, 5 mM MgCl2, 2mM DTT and 1 
protease inhibitor tablet/20 ml buffer). The cells were lysed by sonication for 2x2 minute 
cycles at 4C. Cell debris was removed by centrifugation at 20,000 g for 45 minutes at 4 C, 
using a Beckmann Avanti 30 centrifuge. 0.2 mL of nickel-nitrilotriacetic acid (Ni-NTA) slurry 
per original 1 L culture was added to the supernatant and the mixture was incubated for 3 
h at 4 C. The mixture was centrifuged at 400 g for 1 min and the slurry poured into a 12 ml 
Polyprep column attached to a peristaltic pump. The columns were washed at a flow rate 
of 1ml/min with resin wash buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 20 mM imidazole, 
2 mM DTT, 5 mM MgCl2), until the protein concentration in the eluted was buffer was less 
than 0.1 mg/ml. The pump was removed and the protein was eluted in 1 ml fractions using 
elution buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 20 mM imidazole, 2 mM DTT, 5 mM 
MgCl2). Elution fractions were collected until the concentration dropped below ~0.1 mg/ml, 
with the nanodrop being used to measure protein concentration (Section 3.2.7). Protein MW 
and quality was established using SDS-PAGE analysis (Section 3.2.8). 20% (v/v) glycerol 
was added to all eluates which were frozen at -80oC for storage. 
 
2.2.6 Expression and Purification of mammalian adenylyl cyclase 2C2a domain 
Expression and purification of the tmAC-2C2a domain was carried out in exactly the same 
way as for the 7C1a domain, with the following exceptions.  
- DNA was isolated from E. coli M15 (DE3) containing the pQE60-2C2821-1090 
plasmid (Section 2.2.2).  
- The DNA was transformed into competent M15 (DE3) cells (Section 2.2.3). 
- Antibiotics used in agar and LB media throughout expression were 50 µg/ml 
Kanamycin and 100 µg/ml Ampicillin.   
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2.2.7 Quantification of protein concentration using UV absorbance. 
Protein concentration was measured using a Nanodrop 2000 spectrophotometer. The 
Nanodrop was first blanked using 2 µl of the appropriate buffer. 2 μl of protein solution was 
added to the Nanodrop and absorbance measured at 280 nm. When measuring the 
concentration of a purified protein the known molecular weight and extinction coefficients 
were used to calculate the precise concentration. 
2.2.8 SDS PAGE analysis 
Protein molecular weight and purity was assessed by running the proteins on SDS-PAGE 
gels. A 15% (w/v) gel resolving gel was used with a 5% (w/v) stacking gel. 4x LDS sample 
buffer was added in a 1:3 ratio of protein to sample buffer, and the samples incubated at 
90oC for 5 minutes to denature the proteins. For analysis of wash and elution fractions from 
protein purification a 6 µl sample was taken from a 1 ml fraction and mixed with 2 µl of 
loading buffer. When analysing known amounts of purified protein 5 µg of protein was 
loaded onto the gel. Proteins were loaded onto the gel along with a molecular weight 
standard and electrophoresed at 20 V/cm of resolving gel, in Tris-Glycine running buffer 
(250 mM Tris, 1.92 M Glycine, 1% (w/v) SDS). Protein bands were stained overnight using 
Coomassie Instant Blue.  
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2.3  Materials  
Specific materials are listed in the tables below. All other chemicals and materials used 
were obtained from Sigma Aldrich. 
2.3.1  Protein production materials 
 
 
 
 
 
2.3.2  Purchased proteins 
2.3.3  Carbamate trapping materials 
 
2.3.4 Mass spectrometry materials 
 
 
 
 
Product Source 
CHCA matrix Sigma #70990 
Mass spectrometry grade trypsin Promega #V5111 
 
Product Source 
Haemoglobin (Human) Sigma #H7379 
Rubisco (Spinach) Sigma #R8000 
 
Product Source 
Imidazole Melford # B4005 
Nickel-nitrilotriacetic (NTA) resin Thermo Fisher # R901-01 
IPTG Melford # MB1008 
QIAprep Spin Miniprep kit Qiagen # 27104 
Coomassie Instant Blue  Sigma # ISB1L-1L 
LB Miller broth (high salt) Melford # GL1704 
LB Agar Melford # GL1706 
Ampicillin  Melford # A0104 
Kanamycin Melford # K0126 
 
Product Source 
Triethyloxonium tetrafluoroborate Sigma #90520 
NaH14CO3 American Radiochemicals Inc  #0138B 
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3 Development of a method for trapping and analysis of 
carbamates 
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3.1   Chapter Introduction 
3.1.1  A new approach to investigating protein carbamylation 
Carbamates are labile groups which can make their discovery elusive and subsequent 
investigation difficult (Lorimer, 1983). Previous studies that have found proteins to form a 
functional carbamate modification have done so in one of two ways. The first of these is 
based on a hypothesis of the mode of action of the protein, which resulted in a search for a 
carbamate. Examples of this occurring are the initial discoveries of carbamylated 
haemoglobin, Rubisco and connexin 26 (Rossi-Bernardi and Roughton, 1967, Lorimer and 
Miziorko, 1980, Meigh et al., 2013). Alternatively some carbamates have been discovered 
as a by-product of experiments with different aims. An example of this is the discovery of 
the carbamylation of OXA 10 of the Class D β-Lactamases, which was found by analysis of 
the crystal structure of the protein with no prior hypothesis of carbamate formation 
(Maveyraud et al., 2000). Discoveries such as this one may lead to other proteins of the 
same family or similar structures also being found to form carbamates through intentional 
investigations into carbamylation. This is the case for other members of the Class D β-
Lactamases and the related BlaR signal transducer protein (Leonard et al., 2013). 
There is nothing wrong with the approach taken by any of the above studies; in each the 
function or structure of a particular protein was being investigated, which either confirmed 
the hypothesis of a carbamate or revealed the presence of one. However, the discovery of 
the important role of a carbamate group in the mechanism of Class D β-Lactamases only 
arose after analysis of the crystal structure of OXA-10. This indicates that there may be 
many cases of functional carbamate formation that we are yet unaware of. In addition not 
all carbamates may be discovered as readily as in the case of the Class D β-Lactamases, 
where the crystallisation conditions were favourable to carbamate formation. As carbamates 
are unstable it is less likely that they will be discovered by chance, as the experimental 
conditions would have to be favourable to their formation.  
We decided to take an alternative approach to investigating carbamate formation, which 
was to focus first on identifying whether a protein forms a carbamate and then secondly 
how this may impact upon its function. It was hypothesised that this approach could be used 
to screen multiple proteins simultaneously for carbamate formation, potentially leading to 
the discovery of new cases of functionally important carbamates in a much more efficient 
manner than previously. To avoid the problem of carbamates dissociating from the protein 
and impacting the results, it would be necessary to first stabilise or trap the carbamate 
modifications. In this way proteins could then be analysed without the labile carbamates 
being lost during the experimental process. 
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3.1.2  A carbamate trapping method using triethyloxonium tetrafluoroborate  
The trapping reagent used in these experiments is the ethylating agent triethyloxonium 
tetrafluoroborate, (TEO). It has been shown that TEO is capable of reacting with proteins in 
aqueous solutions despite the fact that it hydrolyses rapidly (King et al., 1986). Previous 
work carried out by Victoria Linthwaite (University of Durham, unpublished) had found TEO 
was capable of ethylating carbamylated amine groups, though free carboxyl and neutral 
amine groups on amino acids were also ethylated. Linthwaite developed a method to 
carbamylate amino acids by using sodium bicarbonate to provide CO2 at a physiological 
concentration. The HCO3- then reacts with the N-terminus of the amino acid to form a 
carbamate. The product was analysed by electrospray mass spectrometry and the 
presence of ethylated carbamates proved that the TEO reagent was capable of trapping a 
carbamate as hypothesised. 
3.1.3  Method development and optimisation 
The initial experiments performed by Linthwaite had been used to develop and validate the 
trapping method using a simple system of individual amino acids that was easy to analyse. 
On this basis the first aim in this work was to validate the method on the amino acid 
phenylalanine and then further develop the method for use on a control protein known to 
form a functional carbamate. Once this was achieved it would be possible to optimise the 
method so that it could then be applied to other proteins. For the purposes of method 
development haemoglobin has been used to trial the trapping method on proteins.  
The results obtained from method development and optimisation will be described and 
discussed. The analysis of the trapped carbamates was performed using mass 
spectrometry techniques. This was important as mass spectrometry enables many different 
proteins to be analysed simultaneously through proteomic techniques (Van Riper et al., 
2013). This is essential as the ultimate goal of the project is to be able to identify 
carbamaylated proteins among a large mixture of proteins.  
 
3.2  Establishing a method to control pH during trapping 
experiments 
pH is a critical factor in influencing the outcome of an experiment. TEO hydrolyses rapidly 
to produce a strong acid, constantly lowering the pH of the experimental conditions in a 
trapping experiment. If the pH becomes too low during an experiment, for example below 
pH 6.0, then the amine group on the amino acid or protein will become protonated.  
Carbamates are unable to form on charged nitrogen atoms so this would prevent 
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carbamylation of the substrate. Before any trapping experiments could commence, 
therefore, it was necessary to devise a system to regulate pH during the trapping procedure, 
To counter the pH-altering effects of hydrolysed TEO a NaOH solution was added to the 
experiment to raise the pH. However, if the pH rises too high, for example above pH 8.5, 
there will be very little CO2 in solution as it will mostly be present in the form of bicarbonate.  
Therefore, a Titralab 854 pH Stat was used in order to allow the pH to be closely controlled 
in a trapping experiment. The pH Stat was set to maintain the pH of the solution at pH 7.4, 
at 25oC, and programmed to add NaOH solution at a rate which maintained the required pH 
with the minimum amount of fluctuations possible. Figure 3.2.1A shows an example 
experiment of how the pH meter maintained the pH over a period of one hour when trapping 
a carbamate on the -amino group of phenylalanine, whilst Figure 3.2.1B shows the volume 
of NaOH added over the period in the same experiment. Though the pH fluctuates at the 
start of the experiment the fluctuations are kept within a physiological pH range, and the pH 
becomes more stable over time as the TEO is hydrolysed (Fig 3.2.1A). Over half of the 
NaOH is added within the first 10 minutes of the experiment and by the end of the 
experiment no NaOH is being added (Fig 3.2.1B). This demonstrates that half of the TEO 
is being hydrolysed within the first ten minutes of the experiment and after an hour is 
completely hydrolysed. These results agree with published data which shows TEO has a 
half-life of about seven minutes in aqueous solution (King et al., 1986). This experiment was 
important to determine the length of further experiments as one hour. After this time the 
TEO would lose all ability to trap a carbamate due to hydrolysis. It is probable that most of 
the trapping is occurring when the TEO is first added and at its most reactive. It was 
therefore especially important to control the pH within the first ten minutes.   
This ability to precisely control the pH was also essential for experiments using proteins 
rather than amino acids. Controlling pH is critical to maintain a stable physiological pH for 
proteins and to permit carbamate formation to be representative of that occurring in vivo.  
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Figure 3.2.1: Regulation of pH during the carbamate trapping experiment 
A pH Stat was used to regulate and monitor the pH during TEO trapping experiments. 
Addition of NaOH was used to neutralise the acidity caused by the hydrolysis of TEO 
during the experiment. This data presented here is from a trapping experiment on 
phenylalanine and is representative of all trapping experiments. A) The pH values 
recorded throughout the duration of an hour-long experiment. The arrow indicates the 
time point at which the TEO was added. The dotted line indicates pH 7.4 B) The volume 
of NaOH added throughout the duration of an hour long experiment. The arrow indicates 
the time point at which the TEO was added. 
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3.3  Validating the carbamate trapping method using phenylalanine  
Once a method to control pH for trapping experiment had been developed (Section 3.2.1), 
it was possible to begin an analysis of carbamate trapping. The trapping method was first 
tested on the amino acid phenylalanine to ensure that the TEO reagent trapped a 
carbamate as hypothesised. Phenylalanine was chosen as it possesses a single amine 
group for CO2 to form a carbamate, making analysis of the product unambiguous. The 
reaction mechanism of phenylalanine with CO2 to form a carbamate, followed by the 
reaction of the carbamate with TEO, is shown in Figure 3.3.1A.   
The reaction contained three principle components; phenylalanine, sodium bicarbonate and 
TEO, as described in the Methods (Section 2.1.1). A sufficient amount of phenylalanine was 
used in the reaction to ensure that ample product was available for downstream analysis 
by mass spectrometry. Sodium bicarbonate was added prior to the TEO reagent to provide 
CO2 at a physiological concentration. This allowed carbamates to form at the amine group 
on phenylalanine prior to trapping. A precipitate formed at the end of the reaction. It was 
hypothesised that the precipitate was due to the ethylated groups causing the amino acid 
molecules to become hydrophobic and to aggregate. The product was concentrated by 
lyophilisation. A portion was dissolved in methanol, a suitable solvent for electrospray 
ionisation mass spectrometry.  
The reaction product was analysed using by Liquid Chromatography (LC) coupled to an 
Electrospray Ionisation (LC-ESI) mass spectrometer. Sample products are first separated 
using an LC column, then converted into a fine spray of charged droplets, after which the 
solvent evaporates and the ionised sample is separated according to its m/z values (Ho et 
al., 2003). As electrospray is a relatively gentle form of ionisation as the sample molecules 
tend to stay intact, which aids analysis of the components of a sample.  
There were several potential products of the experiment that could be hypothesized. Firstly 
it was possible that phenylalanine with just an ethylated carbamate would be produced, as 
shown in Figure 3.3.1A. However as TEO is also highly reactive with carboxyl groups, it 
was also likely that the carbamylated product formed would also contain an ethylated 
carboxyl group. In addition it was possible that not all of the phenylalanine would be 
carbamylated. Therefore it was hypothesized that phenylalanine ethylated on either the 
carboxyl or amine groups or on both would be present in the product. In addition, there was 
a probability that unmodified phenylalanine would be present in the product, though we 
hypothesized this was unlikely due to the excess of TEO used. It could be ascertained 
whether any of these compounds were present in the sample by calculating the expected 
m/z value of the potential ions of all these species. 
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Figure 3.3.1B shows a representative analysis from one of three repeats of the trapping 
experiment with phenylalanine. The same products were found in all three experimental 
repeats. The figure shows that three products formed from the experiment, represented by 
three peaks in the order in which the products were eluted from the LC column. The y-axis 
is not representative of the amount of product formed due to the differing ionisation potential 
of products. The first two peaks contain no carbamylated phenylalanine; the first peak (i) 
represents a mass corresponding to phenylalanine ethylated only on the carboxyl group or 
on the amine group. As TEO has been shown to react more strongly with ionised 
carboxylate groups than neutral carboxyl groups (Lundblad, 2014)  it may also preferentially 
modify the carboxylate over the neutral amine group, so it is possible that peak (i) consists 
mainly of phenylalanine ethylated on the carboxyl group. However this hypothesis was not 
explored further.  The second peak (ii) contains phenylalanine ethylated on both the 
carboxyl and amine groups. The third peak (iii) contains the carbamylated species. As 
expected the carboxyl group is also ethylated. It was therefore apparent that TEO was 
ethylating the carbamate as hypothesized, despite also showing reactivity with the carboxyl 
and non-carbamaylated amine group of the phenylalanine. As no starting product was 
observed the TEO appeared to be modifying all the phenylalanine present.  
Although the sizes of the peaks cannot be used to calculate the amount of the product they 
represent, they can be used as an estimate. The peak containing the carbamaylated 
species appeared smaller than the others. This is likely because only a small proportion of 
the phenylalanine forms a carbamate at pH 7.4, as unlike in proteins the amine group is not 
in a privileged environment that can promote stabile carbamylation. Therefore the 
carbamate will be constantly in equilibrium with the charged amine group of phenylalanine, 
so at any one time only a small amount of carbamate will be trapped.  
In summary, TEO was identified as a suitable trapping reagent for carbamates and 
experiments to adapt the method for work with protein could now proceed.  
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Figure 3.3.1: Carbamylation and ethylation of phenylalanine at pH 7.4 
A) The reaction mechanism of CO2 with the amine group of phenylalanine followed by 
ethylation of the resulting carbamate by TEO. B) A 0.12mM solution of phenylalanine 
containing 0.02M NaHCO3 and an excess of TEO was maintained at a pH of 7.4 for one 
hour. The product was analysed by ESI-LC mass spectrometry. Letters and arrows 
indicate peaks: i) m/z =194.110, H
+
 adduct, m/z corresponds to either one ethylation on 
the carboxyl group or one ethylation on the amine group ii) m/z=221.142, H
+
 adduct, m/z 
corresponds to ethylations on the carboxyl and amine groups iii) m/z = 265.131, Na
+
 
adduct, m/z corresponding to an ethylated carbamate and an ethylation on the carboxyl 
group 
A 
B 
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3.4   Developing the trapping method for use on proteins 
 
3.4.1 Trapping experiment using haemoglobin as the model protein 
Once the trapping method had been shown to work with phenylalanine it was adapted for 
use to trap a carbamate on a protein. Haemoglobin was chosen for this development as it 
is widely known to trap carbamates on the N-terminal valine residues of both its α and β 
chains (Kilmartin and Rossi-Bernardi, 1971). It could therefore be used as a positive control 
to ensure that physiologically-relevant carbamates are being trapped and could be detected 
in our analysis. 
Initial trapping experiments with haemoglobin used the same conditions that were used for 
the trapping of carbamates on phenylalanine (section 3.3). The addition of 50mM phosphate 
buffer was used both to maintain physiological pH and stabilise the protein in solution. 
Additional changes, described below, were also in the processing of the sample after 
carbamate trapping had been performed and also in the subsequent analysis of carbamate 
formation. 
3.4.2 Processing the ethylated protein using proteolytic cleavage 
No complex preparation of the phenylalanine sample had been needed prior to mass 
spectrometry analysis. It was necessary to analyse the trapped haemoglobin using mass 
spectrometry, but clearly a protein represents a much larger target for mass spectrometry 
than an amino acid. Further, it was desirable to locate the specific residue on which 
carbamylation was occurring, in this case the N-terminal valine residues of the α and β 
chains of haemoglobin. Therefore, after carbamate trapping had occurred, the haemoglobin 
was proteolytically cleaved into characteristic fragments for analysis by mass spectrometry. 
Trypsin was used for this purpose as it specifically cleaves protein at arginine and lysine 
residues (Olsen et al., 2004). Consequently it produces a reliable ‘peptide fingerprint’ which 
can be used to identify a protein by comparing the masses of the fragments in the 
experimental sample to a database of masses of known identity. If enough matches occur 
it can be reasonably deduced that the protein is present in the sample. This method is the 
basis of protein identification if it is among a large number other proteins in a proteomic 
experiment (Aebersold and Mann, 2003).  
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3.4.3 Analysis of the digested protein using MALDI mass spectrometry 
Matrix-assisted laser desorption ionisation time of flight (MALDI-TOF) mass spectrometry 
was used to analyse trapped digested haemoglobin samples. This was because the MALDI 
technique is both more sensitive and less affected than other mass spectrometry methods 
by potential sample contaminants including salts and surfactants (Pan et al., 2007). Despite 
this, the sample was still dialysed at the end of the trapping experiment to remove as many 
salts as possible. After trypsin digestion the protein fragments were mixed with a matrix and 
spotted onto a MALDI plate to allow them to crystallise. Similar to electrospray mass 
spectrometry, MALDI is a gentle ionisation technique that tends to produce ions with a single 
charge, making it easy to identify the protein fragments by their masses. The ions are 
separated by Time of Flight (TOF) with ions with smaller m/z values travelling faster to reach 
the detector sooner. As the charge of all the ions is the same in MALDI the fragments are 
effectively separated by mass.  
The experiment was intended to discover whether the peptide fragment of haemoglobin 
containing the N-terminal valine residue also contained a trapped carbamate. Any trapped 
carbamates and also the other ethylations that might occur on the protein would change the 
masses of the haemoglobin peptide fragments. A database of all the masses of the potential 
peptide fragments expected was therefore constructed. The database was built using the 
ExPASy PeptideMass tool to generate the theoretical masses of the peptide fragments of 
the haemoglobin α and β chains following trypsin digest. An Excel spreadsheet was then 
designed containing the mass of each of the known peptide fragments plus the mass of an 
ethyl carbamate (72.029 KDa) together with the masses of up to four additional ethylations 
(28.0313 KDa) . It was necessary to calculate the masses of all trapping outcomes on a 
peptide as the potential degree of peptide ethylation was unknown. In addition masses of 
peptide fragments that were ethylated up to four times but not ethyl carbamylated were also 
calculated, in order to understand the overall extent of ethylation of the protein. A snapshot 
of a portion of the Excel spreadsheet is shown in Figure 3.4.3.1. Any masses that were 
found in the experimental that matched with those calculated to contain one or more 
ethylations and/or a carbamate were highlighted in pink.  
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Figure 3.4.3.1: Database of trypsin cleavage fragment masses 
After trapping carbamates on haemoglobin using the TEO method, the sample was 
proteolytically digested using trypsin to generate fragments of characteristic molecular 
masses, allowing for up to one mis-cleavage in a fragment. The masses of all the different 
potential fragments were calculated by adding the mass of up to four ethylations to each 
fragment, as well as the mass of one trapped carbamate in addition to four extra 
ethylations. The mass of a single ethylation was calculated as an addition of 28.0313, and 
the mass of a trapped carbamate as 72.029. These masses were then compared to the 
masses found during mass spectrometry analysis of the haemoglobin, any that matched 
are highlighted in pink.  
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3.4.4  Results of haemoglobin trapping experiments  
Carbamate trapping experiments performed on haemoglobin revealed that the N-terminal 
valine residue was carbamylated. Experiments were repeated several times to confirm the 
findings and optimise the method. For clarity, the results discussed here are those from an 
experiment performed after all optimisation of the method and analysis had taken place. 
The main ways by which the method was optimised is summarised in the following section.  
The overall mass spectrum of the haemoglobin protein fragments is shown in Figure 
3.4.4.1A. The y-axis shows the relative intensity of the fragment ions present in the sample. 
In general the larger amount of an ion there is present in a sample the more intense the 
signal will be, however some fragments ionise more easily than others and so intensity is 
not necessarily an accurate measure of quantity. Clusters of peaks are evident and this 
effect is caused by differing amounts of ethylations from the TEO reagent on the same 
peptide fragment. For example one particular peptide fragment may be present with one, 
two and three ethyl groups attached, creating a cluster of ions that increase in mass in a 
stepwise fashion by the mass of an ethyl group (28.0313) each time. This pattern is here 
denoted an “ethylation series”. The ethylation series were useful in determining the reliability 
of a particular peptide fragment being present in the product sample. If the peptide fragment 
was observed as an ethylation series, we hypothesized it was more likely to be a true result 
than if it was just present with one ethyl group. This was because an m/z value 
corresponding to each additional ethylation on the same fragment effectively represents an 
additional confirmation that the fragment is present in the sample. 
The peptide fragment containing the carbamate on the valine residue of the haemoglobin β 
chain was hypothesized to have the sequence, VHLTPEEK with a m/z value of 952.5098. 
The analysis database (Section 3.4.2) was searched for matches with the mass of this 
peptide fragment plus the mass of an ethylated carbamate group with a potential ethylation 
series. The data was also examined for the VHLTPEEK peptide fragment in its non 
carbamylated form. Figure 3.4.4.1B shows a magnified section of the whole spectrum in the 
appropriate m/z range. All the peaks corresponding to the mass of the VHLTPEEK fragment 
with its different modifications are highlighted in colour. Peaks shown in red are the ion 
masses that correspond to a trapped carbamate on the VHLTPEEK fragment with two, three 
and four additional ethylations. The VHLTPEEK fragment was also observed in a non-
carbamylated form with multiple ethylations, which are indicated in blue. The data therefore 
provided strong evidence that the method had indeed trapped and stabilised the carbamate 
known to form on the N-terminal valine of haemoglobin. The trapped carbamate was found  
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Figure 3.4.4.1: Identity of haemoglobin trypsin digest fragments using MALDI-TOF 
The trypsin cleavage fragments of the haemoglobin were mixed with CHCA matrix and 
then analysed using Matrix assisted laser desorption ionisation time of flight (MALDI-
TOF). The resulting fragment ions are displayed showing mass and intensity. A) The 
whole spectrum of haemoglobin fragment ions. B) A magnified section of the spectrum 
shown in A, showing the ion masses corresponding to the fragment of the haemoglobin β 
chain containing the N-terminal valine residue, VHLTPEEK. Ions with masses 
corresponding to the non-carbamylated VHLTPEEK fragment are shown in blue, with the 
number of ethylations indicated by the number of *. Ion masses corresponding to the  
fragment with a trapped valine carbamate are shown in red, again with additional 
ethylations indicated by *.  
B 
A 
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over at least ten different experiments, showing that the observation was reliable and 
repeatable. The peaks corresponding to the ions of the carbamaylated fragments are low 
in intensity relative to those of the non-carbamylated fragments. This could suggest that 
there was a relatively small amount of carbamate formed, however it is equally possible that 
the carbamylated fragments do not ionise as well, resulting in peaks with a smaller intensity. 
As the main aim of the experiment was to show that a trapped carbamate was present this 
was not a concern, although it was seen as a potential issue to address over time.  
The data demonstrated that it was highly likely that the identity of the fragment hypothesized 
to be carbamylated was VHLTPEEK. However, this conclusion was based on the mass of 
the peptide fragment alone. It was formally possible that the masses observed were a 
coincidental match and actually belonged to other peptide species entirely. A method was 
therefore needed to confirm the identity of the peptide fragment beyond reasonable doubt. 
This was achieved using a technique coupled to the MALDI mass spectrometer called 
tandem mass spectrometry (MS/MS). This technique is able to split the target peptide 
fragment ion into smaller constituent ion fragments, called Y and B ions. Similarly to the 
procedure used to identify the trypsin fragment ions, the Y and B ions formed can be 
compared to the calculated values of all potential Y and B ions. Figure 3.4.4.2 shows the 
results when MS/MS was performed on the ion with a mass corresponding to the 
VHLTPEEK fragment with a trapped carbamate and four additional ethylations. The 
fragment masses with the top ten highest intensities are displayed. Of these five correspond 
to fragments of the VHLTPEEK ion with four of these containing the carbamaylated valine. 
As the presence of just three fragments ions is needed to confirm the identity of a protein 
fragment, it was concluded that the fragment had been correctly identified.  
It can also be seen in Figure 3.4.4.1A that there are three main other collections of peaks 
corresponding to larger fragment masses. These represent series of ethylations on several 
other fragments apart from the carbamate forming VHLTPEEK fragment. This is to be 
expected as there are other carboxylate groups in the protein that will be in a suitable 
environment to undergo ethylation by TEO. It is likely that there are also many smaller 
intensity ethylation series which are not as visible, and that the higher intensities of some 
fragments are due to a combination of a high rate of trypsin cleavage and good fragment 
ionisation in the mass spectrometer. It has been shown previously through radioactivity 
studies that carbamates derived from cyanate may also be found at certain lysine residues 
in haemoglobin, albeit in relatively small quantities. (Lee and Manning, 1973). Cyanate was 
shown to compete with CO2 for carbamylation sites, suggesting that CO2 may also 
carbamylate several different residues in haemoglobin. However in this investigation no 
masses corresponding to other potential carbamylated fragments were found.  
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Figure 3.4.4.2: Confirmation of identity of VHLTPEEK fragment using MS/MS 
MS/MS was used to confirm the identity of the carbamylated VHLTPEEK fragment, by 
splitting it into its constituent ions. The ion corresponding to the mass of VHLTPEEK with 
a trapped carbamate and four additional ethylations, shown in Fig 4.4.4.1B, was chosen 
for analysis. The resulting fragment ions with the ten highest intensities are shown here. 
Peaks indicated in colour represent ions belonging to the VHLTPEEK fragment, with the 
red peaks containing the carbamylated valine residue.  
50 
 
3.5  Optimisation of the carbamate trapping method  
The trapping method was optimised to improve the quality of the results throughout the 
investigation. Although the method was sufficient to identify carbamates on haemoglobin it 
was necessary to improve the efficiency of the trapping and the sensitivity of the analysis 
as much as possible, in order to be able to use the method to identify carbamates on much 
smaller amounts of protein in future. 
The different approaches taken to improve the method are summarised in Table 3.4. The 
main achievements made were to reduce the amount of haemoglobin used from 10 mg to 
1 mg. This was important as it would be necessary to use the method on smaller quantities 
of protein in future. As haemoglobin contains two different chains the actual amount of each 
chain was 0.5 mg. With further optimisation the analysis should become even more 
sensitive.  
The main drawback of the method, which still remains an obstacle, is the precipitated protein 
that occurs as a result of the multiple ethylations by the TEO reagent making the protein 
highly hydrophobic. Though a long trypsin digestion was able to cleave the precipitated 
protein, cleavage would be much more efficient if the protein was in solution. Several 
methods were investigated to solubilise the protein including addition of SDS and heat 
treatment, however these had to be used under conditions compatible with trypsin digestion 
and mass spectrometry. These methods did not greatly improve solubility of the trapped 
protein pellet and SDS tended to interfere with mass spectrometry. However simply shaking 
the sample during trypsin digestion did aid digestion of the precipitate.  
The parameters used to assess experiment improvement were the amount of protein 
fragments produced, amount of carbamylated fragments identified, and the intensity of the 
carbamylated fragments. The differences in results before and after the method 
optimisations shown in Table 3.5 are presented in Figure 3.5.1. It can be seen that although 
the amount of carbamylated fragments did not increase the intensity did. For analysis of 
results all intensities of fragments were considered as it was not known how well any 
particular fragment would ionise, or in what quantity a putative carbamylated fragment 
would be present. However although reproducibility was considered most important in terms 
of analysis, optimisation of the method to increase intensity was desirable as it was an 
indicator of increased efficiency of carbamate ethylation and/or protein digestion, and made 
it easier to perform MS/MS analysis. In addition, the overall number of protein fragments 
released by trypsin digestion increased. This increase will be important for future 
experiments where all the fragments will have to be investigated for carbamates.  
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Table 3.5.1: Summary of approaches taken to optimise the trapping experiment 
Method optimisation  Rational Result 
Dialysis of trapped protein 
before trypsin digestion 
TEO potentially interfering 
with trypsin digestion or 
mass spectrometry 
MALDI results gave higher 
fragment intensity, 
Different amounts of Hb 10 mg, 1 mg and 0.1 mg of 
Hb used to investigate 
minimum amount required 
for carbamate identification 
1 mg was the minimum 
amount needed to identify a 
carbamate.  
Different amounts of TEO  5, 50, 150, 250, 300, 400 
and 500 mg of TEO were 
tested to see if using a 
different amount would 
improve carbamate 
identification. 
250 mg of TEO gave optimal 
carbamate identification. 
Concentration of trapped protein 
by spin column instead of freeze 
drying 
Freeze drying is a slow 
process and wastes 
product. Concentrating is 
much less wasteful. 
No protein lost through 
concentrating so results more 
representative. Faster method. 
Use of CHCA matrix versus SA 
matrix 
Different matrices crystallise 
differently and therefore 
affect fragmentation. 
CHCA matrix produced more 
high quality fragments. 
Zip tip sample vs non zip tip 
preparation for mass 
spectrometry 
Zip tipping can remove 
unwanted salts and be used 
to concentrate sample 
Zip tipping improved mass 
spectrometry data with less 
noise.  
Investigation into methods to 
dissolve pelleted protein 
If able to dissolve pellet 
trypsin digestion would be 
more efficient, leading to 
better mass spectrometry 
results.  
Methods investigated not 
adopted as mass spectrometry 
results either not improved or 
made worse.  
Length of trypsin digestion A longer incubation with 
trypsin could improve 
sample data 
An overnight trypsin digestion 
was adopted, which increased 
amount of protein fragments 
observed. 
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Shaking during trypsin digestion Shaking precipitate during 
trypsin incubation could aid 
digestion 
Shaking increased number of 
fragments identified. 
 
 
 
53 
 
 
 Before Optimisation After Optimisation 
Number of fragments 114 224 
Number of all ethylation series 3 4 
Number of  fragments in 
carbamate ethylation series 
3 3 
Maximum intensity of 
carbamaylated fragment 
1698 2409 
 
A B 
C D 
E 
Figure 3.5.1: Comparison of trapping method before and after optimisation 
Examples of haemoglobin mass spectrum before and after the method optimisation. 
A) Complete mass spectrum of the carbamate trapped haemoglobin analysed by 
MALDI before any method optimisation had taken place. B) Complete mass spectrum 
of the carbamate trapped haemoglobin analysed by MALDI after all method 
optimisation had taken place. C) Section of the mass spectrum shown in A showing 
the VHLTPEEK fragment. Blue peaks represent the non-carbamylated fragment and 
red peaks the trapped carbamylated fragment. D) Section of the mass spectrum shown 
in B showing the VHLTPEEK fragment. Blue peaks represent the non-carbamylated 
fragment and red peaks the trapped carbamylated fragment. E) Table comparing result 
parameters before and after experiment optimisation. 
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3.6  Chapter summary 
It has been shown here that a general method has been developed to trap a carbamate 
modification onto haemoglobin by ethylating the carbamate using TEO as an ethylating 
agent. It is possible to analyse the ethylated protein and identify the trapped carbamate by 
MALDI and electrospray mass spectrometry. The method has been optimised to identify the 
optimum conditions for the experiments, although further optimisation may be required in 
future for different proteins and or different experimental formats. 
Therefore the method can now be used to investigate whether other proteins that are 
regulated by CO2 also form carbamate modifications, as will be discussed in the next 
chapter.  
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4 Investigating carbamate formation on Class III 
adenylyl cyclases 
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4.1  Chapter Introduction 
The carbamate trapping method described in Section 3.0 had been shown to work on both 
haemoglobin and Rubisco. Therefore the method could now be used to explore carbamate 
formation on proteins not previously known to bind CO2 as a carbamate. Class III adenylyl 
cyclases (ACs) were investigated as they have previously been shown to be responsive to 
CO2 and it was hypothesised that this could be through the formation of a carbamate.  
4.1.1  Regulation of Class III adenylyl cyclases by CO2 
Adenylyl Cyclases (ACs) are found in both prokaryotes and eukaryotes and catalase the 
formation of the second messenger cyclic adenosine 3′,5′-monophosphate (cAMP) from 
ATP. They are therefore an important component of numerous signalling pathways 
regulating a wide variety of physiological processes (Steegborn, 2014, Sassone-Corsi, 
2012).  
There are six classes of AC. Class I ACs comprise those found in gram negative bacteria 
such as E-coli, whilst Class 2 ACs are those belonging to pathogens such as Pseudomonas 
aeruginosa and Bordetella pertussis, and are secreted like toxins into the host organism 
(McDonough and Rodriguez, 2012, Linder, 2008). All known eukaryotic and a large amount 
of prokaryotic ACs belong to Class III, which is the largest class. (Danchin, 1993, Steegborn, 
2014). The remaining classes IV-VI were more recently discovered and contain as little as 
one AC per class (Steegborn, 2014).  
Mammals possess ten identified class III ACs, nine of which are transmembrane adenylyl 
cyclases (tmAC) and one which is a soluble adenylyl cyclase (sAC) (Linder, 2006). 
Following the discovery that the mammalian sAC could be activated by bicarbonate (Chen 
et al., 2000), the abilities of other class III adenylyl cyclases to respond to inorganic carbon 
were investigated. ACs from several prokaryotic species were also shown to be regulated 
by inorganic carbon but initially this was not thought to be the case for mammalian tmACs 
(Kamenetsky et al., 2006) 
Initially there were no attempts to separate the inorganic carbon into CO2 or HCO3- so it was 
uncertain which species was regulating the ACs, though it was generally assumed to be 
bicarbonate due to the hypothesis that the ionic molecule was more likely to bind in the 
active site than CO2 (Steegborn et al., 2005, Raven, 2006). However a study that did 
investigate the individual  effects of CO2 and HCO3- found that two prokaryotic class III 
adenylyl cyclases form cyanobacteria,  Slr1991 from Synechocystis PCC 6803 and CyaB1 
from Anabaena PCC 7120, responded to CO2 but not HCO3- (Hammer et al., 2006).  
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On this basis the mammalian tmACs were again investigated to see if they were responsive 
to CO2 and/or bicarbonate. It was shown that both a mammalian tmAC  and the related 
Rv1625c AC of Mycobacterium tuberculosis were stimulated by CO2 but not bicarbonate 
ions, an effect which occurred  independently of pH (Townsend et al., 2009). On the other 
hand sAC was found to respond both to CO2 and HCO3.  Additionally it was shown that 
radioactively labelled CO2 was able to bind to the catalytic region of the Rv1625c AC from 
Mycobacterium tuberculosis independently of any cofactors, suggesting that CO2 could be 
activating it by directly binding to the protein (Townsend et al., 2009).  
 However there is some uncertainty over whether tmACs can be regulated by inorganic 
carbon alone under physiological conditions in vivo. Experiments investigating the response 
of both sAC and tmAC in the carotid body found that neither of the adenylyl cyclases was 
able to functionally respond to inorganic carbon independently of pH (Nunes et al., 2013). 
As the concentration of bicarbonate/CO2 used exceeded physiological concentrations it is 
possible that any response pathway had lost its sensitivity to the inorganic carbon, though 
this seems unlikely as Townsend et al also used a higher concentration of CO2 and still saw 
an increase in cAMP production, though not above that induced by physiological CO2 
concentrations (Townsend et al., 2009)  It is possible that the ACs of the carotid body are 
regulated by pH alone whereas ACs in other locations are additionally regulated by 
bicarbonate and/or CO2. Another study investigating the response of mammalian G protein 
responsive AC isoforms by measuring cAMP output in three different cell types found a 
reduced response at elevated CO2 concentrations of 10% compared to ‘normal 
concentrations’ of 5% (Cook et al., 2012). This was interesting as previously it was shown 
that CO2 stimulation increased cAMP production (Townsend et al., 2009). The reason for 
this discrepancy is that the CO2 dependent decrease in cAMP output was reliant on an 
active inositol 1,4,5-triphosphate (IP3 receptor), a protein that regulates calcium release 
from the Endoplasmic reticulum (Cook et al., 2012, Mikoshiba, 2007). This would not have 
been accounted for in the study by Townsend et al.  
Therefore although it is accepted that sAC is regulated by bicarbonate, with the possibility 
of being regulated in addition by CO2, the response of the other Class III adenylyl cyclases 
to CO2 is a complex one which is still not fully understood. However in two out of three key 
studies a response of adenylyl cyclase to CO2 in terms of cAMP output was observed, 
though it is now known that cAMP amounts are reduced rather than decreased in vivo 
(Townsend et al., 2009, Cook et al., 2012). In addition the work by Townsend et al showed 
that CO2 appeared to be binding to the Rv1625c AC, further supporting the hypothesis that 
CO2 may be directly influencing the function of tmACs (Townsend et al., 2009). The final 
study was in the specific location of the carotid body where it is possible that the effects of 
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CO2 are different. In addition the authors were expecting levels of cAMP to increase in 
response to CO2 so may have overlooked its potential suppression (Nunes et al., 2013). 
Overall it appears that CO2 does have a pH independent role in regulating Class III ACs 
involving binding of the CO2 to the protein, but further work is required to enable better 
understanding of the mechanisms involved. 
 
4.1.2 Investigating the ability of Class III ACs to form carbamate modifications 
As shown in section 4.1.1 there is a need for further work into firstly, the precise impact CO2 
has on tmACs, and secondly whether it directly binds to them to influence their functions. 
To help provide an answer to the second question it was decided to use the carbamate 
trapping method to explore whether CO2 was forming a carbamate in the catalytic domains 
of  two ACs; a mammalian tmAC and the related Rv1625c AC from Mycobacterium 
tuberculosis.  
The mammalian tmAC consists of two transmembrane domains each containing six 
membrane spanning segments, and two cytoplasmic domains known as C1 and C2 which 
form a heterodimer. The C1 and C2 domains each contain a region of highly conserved 
catalytic residues and are termed C1a and C2a respectively (Whisnant et al., 1996, Tesmer 
et al., 1997).  
Rv1625c is a class III adenylyl cyclase which a useful model of the mammalian tmAC, as it 
corresponds to exactly one half of the protein, consisting of one transmembrane domain of 
six repeats and one cytoplasmic catalytic domain (Reddy et al., 2001).  
The original aim was to investigate the ability of the mammalian tmAC to form a carbamate, 
but when results proved inconclusive the related Rv1625c protein was also tested. Both of 
the proteins have lysine and arginine residues in their catalytic domains with an amine side 
chain which could potentially bind CO2 as a carbamate. The residues of K938 and R1079 
in the in the C2 domain of tmAC and the substrate specifying K296 in Rv1625c were of 
particular interest as these are all conserved residues across different classes of AC known 
to be required for their catalytic activity and function, and as they all have an amine side 
chain could be capable of binding a carbamate (Guo et al., 2001, Liu et al., 1997).  
In order to avoid problems with purifying the membrane domains of the proteins, only the 
catalytic domains were expressed and used in experiments. These domains have 
previously been shown to retain the normal activity of the native proteins and were 
hypothesised to be the most likely to have functional carbamate forming residues, so were 
suitable for our experiments (Whisnant et al., 1996, Townsend et al., 2009).  
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4.2 Expression and Purification of Mammalian tmAC C 1 and C2 
domains 
Two recombinant proteins comprising the catalytic regions of the mammalian 
transmembrane AC were expressed and purified separately. The C1 domain was derived 
from the human type 7 AC and the C2 domain from the rat type 2 AC. It has been previously 
shown that combining these two catalytic domains creates a functional AC (Townsend et 
al., 2009). Both the 7C1 and 2C2 recombinant proteins were overexpressed in E. coli BL21 
(DE3). The hexahistidine tagged protein was then purified using Ni2+ affinity 
chromatography. The protein was eluted from the affinity resin using a buffer containing 
imidazole which competes with the hexahistidine tag for binding to the affinity resin. Eluted 
protein fractions were run on a 15 % (w/v) SDS-PAGE gel for analysis of purity, including 
samples from the wash steps and the original cell lysates before and after incubation with 
resin. 
A representative gel of the purification of the 7C1 domain is shown in Figure 4.2.1A. It can 
be seen that the wash steps were effective in removing the unspecifically bound protein and 
that the majority of the 7C1 protein appeared to be eluted in the first elution fraction. The 
same results were seen for the 2C2 domain. Equal volumes of the purified protein from the 
first elutions of the tmAC 7C1 and tmAC 2C2 domains was also loaded onto a separate SDS-
PAGE gel. The majority of each protein migrated at a molecular weights of ~25 KDa and 
~27 KDa for the C1 and C2 domains respectively. This was surprising given that the expected 
molecular weights of each protein were 42.8 KDa and 31.8 KDa respectively. However 
when the identity of each protein was analysed by peptide fingerprinting using the MASCOT 
database it was confirmed that the identities of each of the proteins was correct with over 
95% confidence in the resulting scores. 
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Figure 4.2.1: Purification of tmAC C1 and C2 domains 
A) Representative SDS-PAGE gel of different stages of the purification of tmAC C1 domain 
from BL21 (DE3) E. coli lysate. Purification of the tmAC C2 domain was carried out in an 
identical manner.  All protein is stained with Coomassie blue and the molecular weight 
standards are indicated on the left hand side of the gel. Lanes 1-4) Separate fractions after 
eluting protein with imidazole, with each fraction eluted using 1ml of elution buffer. The 
molecular weight of tmAC C1 is 26.2KDa, and the vast majority of protein is seen at ~25KDa. 
Lane 5) Whole cell lysate before incubation with resin Lane 6) Whole cell lysate after 
incubation with Nickel resin, pre wash. Lane 7) Nickel resin column flow through after three 
washes.  
B) SDS-PAGE gel of purified tmAC C1 and C2 from the first elution steps, with equal volumes 
of each elution loaded onto the gel. C1= tmAC C1 domain, C2 = tmAC C2 domain 
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4.3 Expression and Purification of Rv1625c204-443  
The cytoplasmic catalytic domain of Rv1625c was expressed as a recombinant protein, as 
it has been shown previously that this this region is adequate for normal activity of the 
protein (Townsend et al., 2009) Rv1625c204-443  was overexpressed in E-coli M15(DE3). The 
hexahistidine tagged protein was then purified using Ni2+ affinity chromatography. The 
protein was eluted from the affinity resin using a buffer containing imidazole which competes 
with the hexahistidine tag for binding to the affinity resin. Eluted protein fractions were run 
on a 15 % (w/v) SDS-PAGE gel for analysis of purity, including samples from the wash 
steps and the original cell lysates before and after incubation with resin (Figure 4.3.1).  
The majority of the eluted protein migrated at a molecular weight of ~25KDa which has a 
predicted molecular weight of 26.3KDa. Therefore it was likely the large band at ~25KDa 
was the expressed Rv1625c204-443 protein. Running samples from the wash steps on the gel 
also showed that the wash methods used during purification were successful in removing 
the majority of proteins bound unspecifically to the resin (Figure 4.3.1). It was estimated 
that the protein was at least 90% pure which was deemed acceptable for use in the 
experiments. The second and sixth elutions shown in Lanes 7 and 11 respectively on figure 
4.3.1A were also analysed by western blot, using an anti-His tag antibody (Figure 4.3.2). 
The tmAC C1 domain protein was also loaded as a positive control for the His tag. A single 
band was seen at ~26KDa in both samples with the second elution containing a lot more 
protein than the sixth elution as expected. This confirmed that the His-tagged protein was 
present in the sample.  Finally MASCOT analysis of a MALDI mass spectrometry 
experiment following trypsin digestion of Rv1625c204-443 identified the protein from its peptide 
fingerprint, with the highest match score of all possible proteins and greater than 95% 
confidence. This confirmed the protein was the main one present in the sample and was 
suitable for use in the trapping experiments.  
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Figure 4.3.1: Purification of Rv1625c204-443  
A) SDS-PAGE gel of different stages of the purification of RV1625c204-443 protein from M15 
(DE3) E. coli lysate. All protein is stained with Coomassie blue and the molecular weight 
standards are indicated on the left hand side of the gel. Lane 1) Whole cell lysate before 
incubation with resin Lane 2) Whole cell lysate after incubation with Nickel resin, pre wash. 
Lanes 3-5) Nickel resin column flow through after three respective washes. Lanes 6-11) 
Separate fractions after eluting protein with imidazole, with each fraction eluted using 1ml 
of elution buffer per fraction. The molecular weight of RV1625c204-443 is 26.2KDa, and the 
vast majority of protein is seen at ~25KDa. 
B) Western blot against His tagged protein using HRP conjugated His-probe. Lane 1: 
Elution 2 of RV1625c204-443 protein shown in Figure 4.3.1A, Lane 2: Elution 11 of 
RV1625c204-443 protein shown in Figure 4.3.1B, Lane 3: positive control (tmAC C1 domain).  
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4.4  Investigating carbamylation of tmAC  catalytic domains using 
MALDI 
The trapping and mass spectrometry methods for analysis for carbamates developed using 
haemoglobin (Section 3.0) were applied to the tmAC C1 and C2 domains to see if either 
formed any carbamate modifications. Both the C1 and C2 domains are required for a 
functional protein and have previously been shown to spontaneously associate to form an 
active catalytic region (Townsend et al., 2009). Therefore the domains which were 
expressed and purified separately as detailed in section 4.2 were mixed together 
immediately prior to the start of the experiment, to allow for the possibility that the domains 
may need to be associated for a carbamate modification to form. NaHCO3 was then added 
to the associated catalytic domains to provide a physiological concentration of CO2 which 
would be able to react with any neutral amine groups with the potential to form a carbamate. 
TEO was added immediately after to allow any carbamates to be ethylated and stabilised. 
The resulting product was then trypsin digested and the fragments analysed by MALDI 
mass spectrometry, as described in the methods section (2.1.8).   
Unlike with the haemoglobin experiments it was not known upon which residue(s) 
carbamylation may occur, although it was hypothesised that they could be those previously 
shown to be important in regulating the activity of the enzyme (Liu et al., 1997, Reddy et al., 
2001). Therefore all of the resulting m/z values from the MALDI experiment were compared 
to all off the theoretical carbamylated and ethylated fragment masses, using a database of 
the same structure as that used in the haemoglobin experiments. Different masses 
representing different amounts of ethyl groups on the same fragment could be used as an 
indicator that that fragment was indeed present and the m/z value not a random occurrence. 
The experiment was performed using both NaH12CO3 and NaH13CO3. This was to ensure 
that any fragment masses that appeared to comprise the mass of a carbamate modification 
with one or more ethylations were true results and not just random masses. If the mass of 
a potential hit appeared in the 12CO2 experiment then if a real result it was expected to also 
appear in the 13CO2 experiment with an additional mass of +1. The fragment could then be 
analysed by MS/MS to confirm its identity and the location of the carbamate.  
Representative images of complete mass spectra from both a 12CO2 and a 13CO2 experiment 
are shown in Figure 4.4.1. Both the 12CO2 and 13CO2 experiment experiments were 
performed at least two times. In theory the two spectra should be very similar in appearance, 
however it can be seen that they appear quite different. When analysed more closely it was 
apparent that many of the same molecular masses were present in the 12CO2 and a 13CO2 
experiments but that the intensities varied greatly. In addition there appeared to be either a 
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larger number of high molecular weight fragments or of low molecular weight fragments 
within an experiment, but not an even mixture of both. For example in the spectrum shown 
in Figure 4.4.1A there are more peaks representing fragments with lower molecular weights 
and these are also more intense than in the 13CO2 spectrum shown in Figure 4.4.1B, where 
the opposite is true.  
This difference between experiments could occur for several reasons. Firstly the extent of 
ethylation itself may vary between different experiments as it is a largely variable process 
producing a differently modified protein each time. Depending on the extent of ethylation 
the ability of the trypsin to cleave the protein may also be affected differentially between 
experiments, producing different cleavage fragments. The fact that there are more high 
molecular weight fragments in the 12CO2 spectrum shown in Figure 4.4.1A could have been 
because this sample was trypsin digested to a lesser extent than the sample which 
produced the 13CO2 spectrum in Figure 4.4.1B. Though the method used was the same for 
both experiments the fact that the trypsin must digest a precipitated protein will inevitably 
make the results less reproducible. In addition there are many factors affecting the MALDI 
mass spectrometry experiment itself that could lead to variable results, for example how 
well the matrix crystallises or how well and reproducibly each fragment ionises. 
Consequently each individual 13CO2  and 12CO2 was repeated at least twice, resulting in the 
carbamate trapping procedure being repeated five times overall. It was hypothesised that 
this should have been adequate to reveal any trapped carbamates. In one 12CO2  
experiment masses were detected which corresponded to the fragment 
VGIHSGNVLCGVIGLR from the tmACC1 domain containing a carbamate with up to four 
additional ethylations (Figure 4.4.2). However the masses did not appear in any of the other 
12CO2 experiemtns and the corresponding masses did not appear in any of the 13CO2 
experiments. It was also surprising that the m/z value for the uncarbamaylated fragment did 
not appear in either its unmodified or ethylated forms. Therefore this m.z value was not 
analysed further as it was likely an artefact of a single experiment and the result could not 
be reproduced.  
 
As no other matches were found between the 13CO2  and 12CO2 expriements for either the 
tmAC C1 or C2 domains it was decided to attempt the experiment on the Rv1625C catalytic 
domain. This was to attempt to confirm whether carbamate formation was occuring on a 
structurally similar adenylyl cyclase, and as it has previously been suggested that CO2 can 
bind directly to this protein it was hypothesised that this could be occuring via a carbamate 
modification (Townsend et al., 2009).  
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Figure 4.4.1: Representative MALDI mass spectra of tmAC C1 and C2 domains 
A) MALDI Mass spectrum of trypsin cleavage fragments of ethylated tmAC C1 and C2 domains 
Equal amounts of each of the domains were combined in a solution containing physiological 
concentrations of CO2 and treated with TEO to ethylate and trap any potential carbamates. 
The products were trypsin digested and analysed by MALDI mass spectrometry. 
B) MALDI Mass spectrum of trypsin cleavage fragments of ethylated tmAC C1 and C2 domains 
using same experimental procedure as for (A) but using 13CO2 instead of 12CO2. 
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Figure 4.4.2: MALDI mass spectra of tmAC C1 and C2 domains 
The MALDI Mass spectrum shown in Figure 5.4.1A was magnified to show m/z values 
including those corresponding to the mass of the VGIHSGNVLCFVIGLR fragment of the 
tmAC C1 domain plus the mass of an ethylated carbamate and up to four additional 
ethylations. The carbamylated fragments are indicated by the red peaks. The * symbol 
denotes an ethyl group.  
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4.5  Investigating carbamylation of Rv1625c catalytic domain using 
MALDI 
It was decided to investigate the carbamate forming capabilities of the Rv1625c adenylyl 
cyclase as a related alternative adenylyl cyclase to the tmAC protein. Again only the 
catalytic site was expressed as this was considered the most likely region in which a 
carbamate would form. Specifically it was hypothesised that the K296 residue was a key 
candidate for carbamate formation. This was due to the lysine reside being conserved 
among adenylyl cyclases for playing an important role in ensuring substrate specificity 
during catalysis (Guo et al., 2001). The advantage of analysing two adenylyl cyclases was 
that as well as providing additional information about each protein, a carbamate modification 
that could be harder to detect on one adenylyl cyclase may be easier to detect on another.  
For example the carbamate forming residues in one protein may be in a less accessible 
environment for TEO ethylation than in another protein. In particular the K296 residue of the 
Rv1625c protein corresponds to the K938 residue of the tmAC C2 subunit (Guo et al., 2001), 
so using Rv1625c was an additional opportunity for investigation of this key lysine residue. 
As explained earlier only the catalytic domain of Rv1625c was expressed, so the 
recombinant protein used was the Rv1625c204-443 protein. 
The Rv1625c204-443 protein was expressed as described in section 4.3. The sample 
preparation and trypsin digestion was performed in the same way as for the tmAC catalytic 
domains, and the protein analysed by MALDI mass spectrometry. As with the tmAC protein 
a database was created containing the masses of all the potential cleavage fragments of 
the Rv1625c204-443 protein in addition to the mass of an ethylated carbamate and up to four 
additional ethylations. At least two experiments were performed where 12CO2 was provided 
as a source for carbamates and at least two experiments where 13CO2 was provided. 
Representative mass spectra from a 12CO2  and a 13CO2 experiment are provided in Figures 
4.5.1A and 4.5.1B respectively. The spectra should in theory look very similar but as with 
the tmAC experiments they tended to vary quite widely between different experiments, 
hence the need for multiple repeats. The reasons for variation are likely the same as those 
for the variation between the tmAC spectra discussed in section 4.4. 
M/Z values corresponding to the mass of the ethyl carbamylated fragment 
LYSAFDELVDQHGLEKIK with up to three additional ethylations were discovered in one 
12CO2 experiment (Figure 4.5.2). This at first appeared promising as the last Lysine residue 
in the sequence was the K296 residue hypothesised to be capable of forming a carbamate. 
However it was not possible to detect the m/z value of the fragment in any of the other 12CO2 
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Figure 4.5.1: Representative MALDI mass spectra of Rv1625c204-443  
A) MALDI Mass spectrum of trypsin cleavage fragments of ethylated Rv1625c204-443. The 
protein was added to a solution containing physiological concentrations of CO2 and treated 
with TEO to ethylate and trap any potential carbamates. The products were trypsin digested 
and analysed by MALDI mass spectrometry. 
B) MALDI Mass spectrum of trypsin cleavage fragments of ethylated Rv1625c204-443 using 
same experimental procedure as for (A) but using 13CO2 instead of 12CO2. 
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or 13CO2 experiments. It was possible that this was due to the fact that the fragment detected 
was a trypsin miscleavege fragment, which occurs when trypsin misses a digestion site so 
what would have been two separate fragments become one. In this case the correctly 
cleaved fragment would have produced a fragment containing the K296 residue of interest 
that was just three amino acids long, too small to be detected by the mass spectrometer. 
Therefore the miscleavege was required so that the K296 residue could be detected, and it 
is possible that in the other experiments this trypsin miscleavage didn’t occur. Therefore for 
the Rv1625c protein too the mass spectrometry results proved inconclusive as to whether 
CO2 formed a carbamate on the protein or not. 
4.6 Chapter Summary 
Overall the results from the mass spectrometry experiments on both the tmAC and the 
Rv1625c catalytic domains were inconclusive. As no carbamates were detected it is 
possible that neither of the proteins forms a carbamate. However for both proteins there 
were m/z values detected that could correspond to the mass of a carbamylated fragment, 
but these could not be reproduced across different experiments.  
Figure 4.5.2: Magnified MALDI mass spectra of Rv1625c204-443 
The MALDI Mass spectrum shown in Figure 5.5.1A was magnified to show m/z values 
including those corresponding to the mass of the LYSAFDELVDQHGLEKIK fragment of the 
protein plus the mass of an ethylated carbamate and up to three additional ethylations. The 
carbamylated fragments are indicated by the red peaks. The * symbol denotes an ethyl group. 
These masses were only found in a single experiment, in subsequent experiments they could 
not be reproduced.  
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It could be seen that the mass spectra appeared quite different in different experiments 
when they should have been more similar. Therefore it is possible that a lack of 
reproducibility in the technique meant that the m/z values of the carbamylated fragments 
were not present in all experiments. On the other hand the carbamylated fragments 
appeared consistently in the control haemoglobin experiments discussed in Section 3, 
therefore the technique was reliable enough to give this results.  
Another potential factor that could influence the detection of carbamylated fragments is the 
position of any potential carbamate modification within the protein itself. It is possible that 
the haemoglobin carbamate on the N terminus of the protein is very accessible to the TEO 
reagent and therefore easily ethylated and stabilised. Potentially carbamates in a region of 
a protein that is less accessible will not be stabilised well and therefore less will be detected 
in the analysis.  
To overcome these problems it was decided to approach the question using a different 
method not involving mass spectrometry, using 14CO2 labelling of the carbamates. This 
method and the results will be discussed in section 5.0. 
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5 Investigation of potential carbamylation of Rv1625c 
using 14CO2  labelling 
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5.1  Chapter Introduction 
It has been demonstrated that MALDI mass spectrometry was not successful in showing 
whether the catalytic domains of either tmAC or Rv1625c  are carbamylated. In the case of 
the Rv1625c protein this was most likely due to the positioning of the trypsin cleavage site 
(Section 4.5).  As Rv1625c204-443 protein had previously been shown to bind CO2 (Townsend 
et al., 2009) and was also able to be expressed in higher yields than the tmAC domains, it 
was decided to proceed with this protein. Therefore an alternative method was investigated 
to demonstrate whether the K296 residue in the catalytic domain of Rv1625c formed a 
carbamate. 
Radioactive labelling using 14C is a technique that has been used in a variety of different 
situations to investigate whether a material binds or incorporates CO2 in the form of 
carbamates (Lorimer and Miziorko, 1980, Golemi et al., 2001, Townsend et al., 2009). It 
was hypothesized that carbamates formed from 14CO2 derived from radioactively labelled 
NaH14CO3, would be trapped by the TEO reagent, resulting in 14CO2 being stably introduced 
onto the protein. We also hypothesized that radioactive bicarbonate or carbon dioxide not 
covalently bound to the protein could be washed away using an acidic buffer. This washing 
should both physically remove the 14CO2 as well as causing remaining bicarbonate to 
convert to gaseous CO2 because of the low pH, enabling it to diffuse out of the solution. 
Washing unbound NaH14CO3 from the protein is simplified due to the highly hydrophobic 
nature of the ethylated protein causing it to precipitate. This means that the precipitated 
protein can be re-suspended in washing buffer then centrifuged to collect the protein 
precipitate again. The washed protein precipitate may then be mixed with a suitable 
scintillation fluid and the amount of 14C radioactivity from trapped carbamates analysed 
using a scintillation counter. 
It was therefore decided to use this approach as an alternative method to investigate 
whether Rv1625c was able to bind CO2 as a carbamate. As previously discussed, K296 of 
Rv1625c is predicted as the most likely residue of the protein to bind a functional carbamate, 
due to its position in the active site of the protein being conserved with the bicarbonate 
binding active site in soluble adenylyl cyclase. The same recombinant RV1625c204-443 
protein (containing the catalytic domain of Rv1625c) that was used in the mass 
spectrometry experiments of section 4.5 was also used in the 14CO2 radioactivity assays to 
investigate this hypothesis. It was hypothesised that if a carbamate is indeed forming at the 
K296 residue of Rv1625c204-443, mutating this residue to alanine should ablate the ability of 
Rv1625c204-443 to form a carbamate. As an additional control an Rv1625c204-443 K397A 
mutant protein was also used. In this protein the K397 residue is not hypothesized to have 
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any carbamate forming properties (though the possibility cannot be formally excluded). 
Therefore when mutated to an alanine the protein should show no differences in carbamate 
formation to the wild type Rv1625c204-443.  
In addition to the Rv1625204-443 proteins, control proteins were also included in the assay. 
These were Rubisco, natalase and Rx1. Rubisco was used as a positive control as it is 
known to form carbamates on Lys201 residues in its large subunits (see section 1.3.2) and 
has been used in similar radioactivity trapping experiments (Lorimer and Miziorko, 1980, 
Stec, 2012). Natalase is a synthetic α-amylase enzyme used in detergents (Kasturi et al., 
2010) and Rx1 is a plant Nucleotide-Binding Leucine Rich Repeat (NLR) immune receptor 
(Fenyk et al., 2015). Both natalase and Rx1 were selected as negative controls as they 
have no identified ability to bind CO2 (though the possibility of this cannot be excluded), and 
were readily available for use. 
The Rubisco, natalase and Rx1 proteins were all available for purchase or had previously 
been made. The wild type recombinant protein Rv1625c204-443 was expressed and purified 
as described previously in Section 4.3. The two mutant Rv1625c204-443 recombinant proteins 
that were produced for this experiment were Rv1625c204-443 K296A and Rv1625c204-443 
K397A. 
5.2  Expression and Purification of Rv1625c204-443 mutants 
Rv1625c204-443 K296A and Rv1625c204-443 K397A proteins were overexpressed in M15 (DE3) 
E-coli. The hexahistidine tagged Rv1625c proteins were then purified using Ni2+ affinity 
chromatography. The proteins were eluted from the affinity resin using a buffer containing 
imidazole which competes with the hexahistidine tag for binding to the affinity resin. Eluted 
protein fractions were run on a 15 % (w/v) SDS-PAGE gel for analysis of purity, including 
samples from the wash steps and the original cell lysates before and after incubation with 
resin (Figures 5.2.1 and 5.2.2).  
The majority of the eluted protein migrated at a molecular weight of ~25KDa for both the 
RV1625c204-443 K296A and RV1625c204-443 K397A proteins, which have predicted molecular 
weights of 26.3KDa. Therefore it was likely the large band at ~25KDa was the expressed 
Rv1625c protein. This was confirmed by trypsin digesting the proteins and analysing the 
fragments using MALDI mass spectrometry. It was confirmed that each of the proteins was 
derived from the Rv1625c protein from Mycobacterium tuberculosis. It was estimated that 
each of the proteins was at least 90% pure which was deemed acceptable for use in the 
experiments. Running samples from the wash steps on the gel also showed that the wash 
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methods used during purification were successful in removing the majority of proteins bound 
unspecifically to the resin (Figures 5.2.1 and 5.2.2).  
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Figure 5.2.1: Purification of Rv1625c204-443 K296A mutant  
SDS-PAGE gel of different stages of the purification of RV1625c204-443 K296A protein from 
M15 (DE3) E. coli lysate. All protein is stained with Coomassie blue and the molecular 
weight standards are indicated on the left hand side of the gel. Lane 1) Whole cell lysate 
before incubation with resin Lane 2) Whole cell lysate after incubation with Nickel resin, 
pre wash. Lanes 3-5) Nickel resin column flow through after three respective washes. 
Lanes 6-11) Separate fractions after eluting protein with imidazole, with each fraction 
eluted using 1ml of elution buffer per fraction. The molecular weight of RV1625c204-443 
K296A is 26.2KDa, and the vast majority of protein is seen at ~25KDa. 
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Figure 5.2.2: Purification of Rv1625c204-443 K397A mutant  
A) SDS-PAGE gel of different stages of the purification of RV1625c204-443 K397A protein 
from M15 (DE3) E. coli lysate. All protein is stained with Coomassie blue and the molecular 
weight standards are indicated on the left hand side of the gel. Lane 1) Whole cell lysate 
after incubation with Nickel resin, pre wash. Lanes 2-4) Nickel resin column flow through 
after three respective washes. Lanes 5-12) Separate fractions after eluting protein with 
imidazole, with each fraction eluted using 1 ml of elution buffer per fraction. The molecular 
weight of RV1625c204-443 K397A is 26.2KDa, and the majority of protein is seen at ~25KDa. 
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5.3  Trapping experiments on Rv1625c204-443 recombinant proteins 
using 14CO2 
The abilities of the Rv1625c204-443 wild type and mutant proteins to form a carbamate were 
then explored using the 14CO2 binding assay described in the introduction to this chapter 
(Section 5.1). For each experiment the percentage of 14CO2 trapped was calculated by 
dividing the number of radioactive counts in the washed protein precipitate by the number 
of radioactive counts at the start of the reaction when the NaH14CO3 was added. The 
concentration of NaH14CO3 was negligible compared to the 20mM NaH12CO3 in the reaction. 
Therefore the percentage of 14CO2 bound could be used to calculate the total amount in 
moles of carbamylated protein in a solution containing 20mM NaH12CO3, using the following 
formula: 
Moles of CO2 bound to protein = % of 
14CO2 bound x moles of NaH
12CO3 used 
It was predicted that any 14CO2 binding to an amine group as a carbamate would be trapped 
and stabilised by the TEO reagent, thereby also fixing the radioactivity onto the protein. On 
this basis Rubisco should form the most carbamate as each of the eight large subunits of a 
Rubisco molecule can bind a molecule of CO2. Therefore a fully carbamylated mole of 
Rubisco can bind eight moles of CO2 as a carbamate. As Rv1625c204-443 is hypothesised to 
have only one carbamylation site, the number of moles of CO2 bound to Rubisco was divided 
by eight, to make the results more comparable to the other proteins used in the experiment.  
Background radiation measurements were first carried out by measuring the radioactivity of 
protein precipitates in experiments where no 14C was added. The average of the raw data 
values for all proteins (which was 30 Decays per minute) was subtracted from all other 
experimental results. As a reference the initial 14C radioactivity of a sample was in the region 
of 20,000-30,000 Disintegrations per Minute (DPM), so the background radiation was about 
1000 times less in comparison. It was also necessary to carry out this type of control to 
ensure that no protein precipitate was creating an abnormally high background reading that 
would interfere with experimental results.  For example, it was found that haemoglobin 
precipitated by TEO greatly interferes with the readings of the scintillation counter, possibly 
due to its chromophore, giving high readings of radioactivity counts even when the sample 
contained no 14C (Figure 5.3.1). Interestingly haemoglobin precipitated with acetone still 
had higher than average background readings but they were much lower than the TEO 
precipitate. As the TEO precipitate tended to be much denser than the acetone precipitate, 
this could explain the results. Therefore although haemoglobin was used as a positive 
control in the mass spectrometry experiments, it could not be used it in this experiment and 
so Rubisco was the positive control used.  
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Figure 5.3.1: Haemoglobin precipitated by TEO gives false radioactivity reading 
Each protein was tested in the radioactivity experiment for false background reading, as 
sometimes precipitated protein could artificially increase the number of perceived 
radioactivity counts by the scintillation counter. Haemoglobin was either mixed with  
NaH14CO3 and precipitated with TEO before excess radioactivity was washed off , or as a 
negative control not exposed to any radioactivity and just precipitated with TEO, as 
described in the methods section. It can be seen that the negative control produced more 
radioactivity counts than the experimental protein, despite not being exposed to any 
radioactivity. The experiment was repeated two times for the negative control and four 
times for the actual trapping experiment. The TEO haemoglobin precipitate was clearly 
interfering with the readings from the scintillation counter.  
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Control experiments using no TEO were also repeated three times for each protein, to 
ensure only 14CO2 bound as carbamates was being detected (Figure 5.3.2A and 5.3.2C). 
The average of the ‘no TEO’ control values calculated for each proteins were subtracted 
from the relevant protein’s results, to make sure all readings of 14CO2 were due to carbamate 
formation only. 
To clarify the terminology used throughout this section with regard to carbamate binding: a 
‘site specific’ or ‘specifically bound’ carbamate is used to describe a carbamate bound to a 
residue in a site specifically designed to form a carbamate, and which is therefore likely to 
have a functional role. The K201 residue in Rubisco is an example of a specific carbamate 
binding residue, as is the K70 in the Class D B-Lactamase OXA-10 (Li et al., 2005). These 
sites may be designed to facilitate carbamylation by stabilising interactions with 
neighbouring residues, or by having properties which favour the neutral state of the lysine 
residue, for example by creating a hydrophobic environment (Leonard et al., 2008, Leonard 
et al., 2013). ‘Unspecific’ or ‘background’ carbamylation is used as a hypothetical 
explanation to account for the possibility that carbamates could form at random amine side 
chains or N-terminal residues. These residues could be capable of binding a carbamate 
due to having a free amine group, but are likely not specialised to do so. Therefore any 
carbamate bound will have done so by chance and there will be much lower levels of 
carbamate formation than would be expected if the residues were in an environment 
designed to bind functional carbamates.  
Results are displayed in units of moles of CO2 bound per mole of protein and also moles of 
CO2 bound per mg of protein. The data from CO2 bound per mg of protein (Fig 5.3.2D) was 
used to calculate the molar results (Fig. 5.3.2B).  It was found that Rubisco bound on 
average 0.52 moles of carbamate per mole of protein, after normalising for the eight putative 
carbamate binding sites as previously described (Fig 5.3.2B). As a protein known to form 
carbamates and the positive control for the experiment the result for Rubisco was expected, 
though the amount of carbamate formation was less than the potential maximum of a 1:1 
molar ratio of CO2: protein.  
The other control proteins Rx1 and natalase showed binding of 0.76 and 0.14 moles of 
carbamate per mole of protein, respectively (Fig 5.3.2B). These results are more surprising, 
as both are proteins with no known ability to bind carbamates. The 0.14 moles of CO2 
binding per mole of natalase showed that the protein was binding a small amount of 
carbamate, but almost four times less than Rubisco, a difference found to be significant. 
This result would suggest that the protein has no specific site designed for carbamylation, 
but that some uncharged amine side chains have bound carbamates in a random manner. 
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This may have occurred during a temporary pH fluctuation altering the pKa value of an 
amine group that wouldn’t normally bind carbamates to allow it do so. In this respect 
natalase is suitable as a negative control displaying some level of ‘background’ carbamate 
formation. However Rx1 showed a greater amount of carbamylation than Rubisco, though 
the difference was not statistically significant. This was unexpected but it is possible that 
Rx1 does have one or more specific carbamate binding sites that are yet undiscovered. 
This would be interesting to investigate using mass spectrometry.  
It was hypothesised that the wild type RV1625c204-443 protein would form a carbamate at its 
K296 residue, and that the K296A mutant would therefore be unable to form a carbamate. 
On the other hand the RV1625c204-443 K397A mutant was hypothesised to show no 
difference in carbamate formation to the wild type protein, as there is no evidence that the 
K397A residue plays a role in carbamate formation. The data demonstrate that all three 
Rv1625c204-443 proteins show a low amount of carbamate formation with values of 0.26, 0.21 
and 0.18 moles of CO2/per mole of protein for the wild type, K296A and K397A proteins 
respectively (Fig. 5.3.2B). Therefore the wild type was binding slightly more carbamate than 
the K296A mutant but the K397A mutant was binding less CO2 than both the wild type and 
K296A mutant proteins. None of the differences between the three Rv1625c204-443 proteins 
were significant when the p values were set at 0.05 or lower.  
The maximum amount of carbamate formation expected for a protein with one specific 
binding site is 1 mole of carbamate per mole of protein. Therefore the Rv1625c204-443 wild 
type protein was only binding 26% of its proposed maximum carbamate capacity, compared 
to the 52% exhibited by the positive control Rubisco and the even greater 76% shown by 
Rx1 (although the number of potential binding sites on Rx1 is unknown). However the wild 
type Rv1625c204-443 protein also almost formed almost double more carbamate than 
natalase. As neither of the differences in carbamate formation between RV1625c204-443 and 
either Rx1 or Rubisco were significant, it is more difficult to conclude whether the adenylyl 
cyclase is binding a significant amount of carbamate or not. However the fact that the K296A 
mutant shows very little decrease in the amount of carbamate formation compared to the 
wild type protein indicates that the protein is not binding a carbamate at the K296 residue. 
In addition the K397A mutant showed even less carbamate formation than the K296A 
mutant, when it was predicted that ablating K397A should have shown no difference from 
the wild type protein. Together these results suggest that the Rv1625c204-443 protein is not 
forming a carbamate at the hypothesised K296A residue. It is most likely the carbamate 
binding displayed by the Rv1625c204-443 proteins and natalase is from a certain amount of 
non-specific carbamate formation at free amino groups in the proteins.  
80 
 
B 
R
V
1
6
2
5
c
R
u
b
is
c
o
N
a
ta
la
s
e
R
x
1
0 .0 0
0 .0 5
0 .1 0
0 .1 5
P ro te in
C
O
2
 b
o
u
n
d
 (
n
m
o
l)
/m
g
 o
f 
p
r
o
te
in
*
*
A 
C 
Figure 5.3.2: CO2 bound to proteins as a carbamate in 14CO2 radioactivity assay 
Amount of CO2 bound as a carbamate to RV1625c204-443 wild type and mutant proteins 
along with different control proteins. Each bar represents the mean of three individual 
experiments, error bars show +/- 1SE of the mean. Control experiments containing no TEO 
trapping reagent show the amount of remaining CO2 on each protein after the washing 
steps in A) moles of CO2 bound per mole of protein and C) moles of CO2 bound per mg of 
protein.  Results from the trapping experiments after subtracting the ‘no TEO’ control values 
are displayed as B) moles of CO2 bound per mole of protein and D) moles of CO2 bound 
per mg of protein. The data displayed in Figures A and B was derived from the data shown 
in Figures C and D respectively. Significance between different groups was calculated for 
all the data using Tukey’s multiple comparisons test. Only significant differences between 
proteins have been indicated, all other differences are not significant.  
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It has to be taken into account that the accuracy of this experimental approach is limited 
because of the levels of ‘unspecific’ or ‘background’ carbamylation that appears to be 
occurring at unspecific amine sites on all proteins. This could lead to misleading results 
unless the true extent of unspecific carbamylation vs site specific carbamylation is 
calculated for the positive control Rubisco. This would be best done by expressing Rubisco 
in E. coli both as a wild type protein and with the carbamate binding K201 residue mutated 
to a residue unable to form a carbamate, for example alanine. This was unable to be 
performed in this experiment due to time constraints, but would be essential for anyone 
using this method in the future. The amount of unspecific carbamylation could then be 
subtracted from results for other proteins in the assay to represent the amount of 
carbamylation at specific sites. This result would still be an estimate as it is possible that 
the amount of unspecific carbamylation may vary depending on the amino acid 
compositions of each protein. For example proteins containing more lysine residues have 
the potential to form more carbamates, and the local pKa values of these residues will also 
influence this. By using more positive controls proteins to calculate the amount of 
‘background’ carbamate formation a more accurate estimation could be formed to overcome 
this problem.  
Whether the amounts of carbamate forming at random amine groups is an artefact of the 
experiment or also occurs in vivo would be interesting to investigate. The pH and the amount 
of CO2 present were designed to reflect the same conditions as would be found in the 
proteins physiological environment. However this is very hard to precisely determine and 
so these factors could have caused unusual carbamates to form at unlikely residues. 
Similarly the conditions used could affect the amount of carbamate formation at sites 
specifically designed to bind carbamates. This could explain why not as much carbamate 
formation was seen for Rubisco as could be expected; it is known that the pH of the plant 
cytosol increases during the light reaction of photosynthesis, which could directly impact on 
levels of Rubisco carbamate formation (Yin et al., 1991).  
In addition, despite efforts to control the pH, it would occasionally fluctuate to levels as high 
as pH 8.5 during the experiment, which could have led to ‘unspecific’ carbamates forming 
at amine groups that CO2 wouldn’t usually bind to, and being trapped by TEO. Another 
possibility producing the opposite effect is the competition between CO2 and the TEO 
reagent for the neutral amine group, as TEO is able to ethylate an amine with or without a 
trapped carbamate. Although the carbamates should have formed before the addition of the 
TEO they are labile. It is possible that a temporary dissociation of a carbamate from an 
amine group would allow TEO to ethylate the amine, blocking any future carbamylation. 
However this effect is less likely to occur with carbamates bound in a site specific manner, 
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as they will be more stable than carbamates bound at non-specific amine sidechains. It is 
clear that whether that carbamate formation also occurs in vivo at unspecific sites or is an 
artefact of the experiment, better controls are needed in the experiment to allow all the 
experimental results to be comparable to each other.  
Finally the results discussed have focused on the amount of carbamate formation per mole 
of each protein (Fig. 5.3.2B) Comparing the amount of carbamate formed using moles as 
the unit of protein is essential the proteins are binding a carbamate at a specific binding site 
only. In this case comparing the carbamates bound using the same masses of each protein 
would be misleading, as those with larger molecular weights would have far fewer binding 
sites present than those with smaller molecular weights. However as already mentioned at 
the beginning of this section the amount of carbamate bound per mg of protein (Fig. 5.3.2B), 
was used to calculate the molar data. This was due to limits on the amount of protein 
available to use. It has been shown that there is a level of unspecific carbamate formation 
among all proteins. However it has been impossible to calculate the amount of unspecific 
carbamate without the use of a Rubisco mutant. Therefore when calculating the amounts 
of carbamate bound per mole of protein from the mass data the unspecific carbamates have 
been included in the calculation. By comparing the two sets of data it can be seen that the 
values of carbamate formation in Figure 5.3.2D are much more similar than those in Figure 
5.3.2B. It is possible that when calculating the molar data the results have been skewed in 
favour of Rx1 and Rubisco which have larger molecular weights forming more carbamate. 
Alternatively it is possible that the correlation between protein molecular weight and 
carbamate formation is coincidental. With the use of a mutant of the carbamate binding 
residue in Rubisco this potential problem could be solved by subtracting ‘background’ 
carbamylation from the mass data before it was used to calculate the molar data.  
5.4 Chapter Summary  
Overall the results from these experiments suggest that the K296 residue in the active site 
of the Rv1625c protein is not a specific carbamate binding residue. This is based on the 
evidence showing there was a very small and insignificant difference between the amount 
of carbamate bound by the RV1625c204-443 wild type and K296A mutant proteins (Figure 
5.3.2B). If the K296 residue was responsible for carbamate formation a significant drop in 
carbamate formation would have been expected. In addition the K397A mutant showed 
even less carbamate formation than the wild type protein, though again this difference was 
non-significant (Figure 5.3.2B). It is therefore likely that the difference seen between the 
wild type and K397A proteins is not real. The overall small amount of carbamate formation 
in all the Rv1625c204-443 proteins compared to the positive control Rubisco and also Rx1 
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further suggests that the Rv1625c protein does not have any specific carbamate binding 
sites.  
The limitations of the experiment in regard to all proteins forming a certain amount of 
carbamate also have to be taken into account. The obvious way to measure the amount of 
unspecific carbamylation in a protein is to mutate the site that is carbamylated. Due to the 
timescale of this project we were unable to create a Rubisco mutant, which would have 
provided valuable information as to how much of the CO2 binding is specific. However the 
putative K296 carbamylation site in RV1625c204-443 was mutated, and the differences 
between the mutant proteins were still not significant. Another possibility is that a potential 
carbamate in Rv1625c204-443 may not be accessible to ethylation. If this is the case it means 
that using TEO as an ethylating agent will need to be further assessed using more positive 
control proteins, to establish how accessible carbamates are to ethylation. Therefore the 
results from this experiment indicate that Rv1625c204-443 does not form a carbamate at the 
K296 residue, however further investigation is required to confirm this result.  
These results do not mean that the Rv1625c adenylyl cyclase is not binding to CO2 at all.  
There is clear evidence in the literature that both mammalian transmembrane adenylyl 
cyclase and Rv1625c is activated by CO2 and that it is probably this occurs by CO2 binding 
to the protein (Townsend et al., 2009).  It is possible that Rv1625 is binding CO2 in a form 
that is not a carbamate, potentially at a different residue to Lys296 of the active site, or in a 
way that necessitates the interaction of several different residues and not just the single 
Lys296 residue. In addition, past experiments that have shown an interaction with CO2 were 
carried out at a relatively low pH of 6.5 compared to the pH of 7.4 in this experiment 
(Townsend et al., 2009). The likelihood of a carbamate forming at this pH is slim due to the 
fact that most lysine residue will be charged due to the increased number of H+ ions in the 
environment. Rubisco is known to function best at a pH of 7.8 or higher due to increased 
carbamylation. Therefore it is not entirely unsurprising that the Rv1625c proteins do not 
appear to be forming carbamates. 
The high amount of carbamate formed on Rx1 is an unexpected and interesting result. Little 
is known about the effects of CO2 on the plant innate immune response, however one study 
found that high atmospheric CO2 increased pathogen aggressiveness in Arabidopsis 
thaliana, through a proposed pathway involving leaf epidermal changes (Lake and Wade, 
2009). Whether CO2 could also potentially modify immune proteins like Rx1 through 
carbamylation requires further investigation. This finding highlights the potential of this 
radioactivity assay using TEO as a trapping agent as a simple method of discovering 
whether a protein binds carbamate or not, once better negative controls have been 
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established. However the assay has limitations compared to a mass spectrometry method 
in that it cannot be used to locate and confirm the identity of a carbamate binding residue. 
In addition it cannot be used on multiple proteins simultaneously and identify which proteins 
bind carbamates, which a mass spectrometry based method has the potential for.  
An additional benefit of this assay over previous ones is using TEO as a trapping agent that 
is able to stably bind carbamates whilst allowing the vast majority of other loosely bound 
radioactivity to be washed off (Figure 5.3.2A and 5.3.2C) This is useful as it results in very 
low background radioactivity from CO2 bound in other ways to the protein. This is an 
advantage over similar radioactivity assays, which often simply separate bound and 
unbound CO2 using a sephadex column (Townsend et al., 2009, Golemi et al., 2001). These 
methods do not guarantee that the radioactivity measured is due to CO2 bound as 
carbamates alone. The methylating agent diazomethane has been combined with a 
radioactivity assay in the past to trap and identify carbamate binding on Rubisco (Lorimer 
and Miziorko, 1980). However the conditions used in this experiment required organic 
solvents and low temperatures which were highly artificial, as well as hazardous. Therefore 
TEO appears is a more desirable trapping agent as it can be used in an aqueous buffer 
under normal temperatures to represent the physiological environment of the protein, and 
is also less hazardous.   
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6 Final discussion and future work 
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6.1 Final discussion 
Carbamate modifications occur when the nitrogen atom of a neutral amine makes a 
nucleophilic attack upon the carbon atom of a carbon dioxide molecule. This leads to the 
CO2 becoming attached to the amine group as a carbamate. It has been shown that 
carbamates can play important functional and structural roles in proteins. There are also an 
increasing number of studies showing that inorganic carbon plays an important role in many 
signalling pathways and processes independently of pH (Jones et al., 2007, Miller et al., 
2014, Smith et al., 2013, Hallem et al., 2011, Taylor and Cummins, 2011). Despite this, the 
mechanisms of inorganic carbon signalling are often not investigated further and in many 
cases remain a mystery. It is possible that CO2 could be binding to and influencing the 
functions of the proteins in these systems via a carbamate modification at lysine residues, 
the N terminus, or possibly arginine residues (Meigh, 2015).  
This first aim of this project was to develop a method to trap carbamate modifications onto 
proteins by ethylation using the chemical reagent Triethyloxonium tetrafluoroborate (TEO), 
to allow their analysis by mass spectrometry. It has been shown in Section 3.0 that a TEO 
trapping method initially developed by a colleague (Victoria Linthwaite) was successfully 
used to trap an N terminal carbamate on the amino acid phenylalanine. The method was 
then successfully adapted for use on a protein using haemoglobin as a positive control for 
carbamate formation. It was shown from these experiments that TEO could effectively trap 
a carbamates on the N-terminal valine residues of haemoglobin α and β chains, which are 
known to form the modification(Kaplan et al., 1982) MALDI and Electrospray Mass 
Spectrometry analysis were used to identify the fragment from its molecular weight, with 
MS/MS was used to confirm the identity of the fragment from its individual amino acids. 
Work to refine and optimise the method also succeeded in producing higher quality and 
more consistent results compared to initial experiments.  
The second aim of the project was to use the trapping and mass spectrometry methods 
developed on a protein shown to respond to CO2, and with the potential to form a carbamate. 
Under these criteria two recombinant transmembrane adenylyl cyclases were tested to see 
if they underwent carbamylation, the C1 and C2 catalytic domains from the mammalian 
tmAC and the related catalytic domain of the Rv1625c protein from Mycobacterim 
tuberculosis. These proteins were chosen as they have been shown to respond to inorganic 
carbon and specifically molecular CO2 (Townsend et al., 2009, Nunes et al., 2013), in 
addition to possessing conserved lysine and arginine residues in their active sites which 
could potentially be capable of forming a carbamate (Liu et al., 1997, Linder, 2006). 
However initial results shown in Section 4.0 did not show any convincing evidence for 
carbamylation of either of the catalytic domains of the mammalian tmAC. Although one 
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protein fragment of the C1 domain that appeared in one experiment had a mass that 
corresponded to the presence of a trapped carbamate, this mass did not appear in any 
other experiments. Therefore the same experiments were performed on the related 
Rv1625c204-443 protein, as an alternative adenylyl cyclase thought to bind CO2 (Townsend et 
al., 2009). Initially results appeared positive as several masses appeared in one experiment 
corresponding to a carbamylated and ethylated LYSAFDELVDQHGLEKIK fragment, of 
which the second lysine residue (K296) plays a key role in the active site of the protein 
(Townsend et al., 2009, Guo et al., 2001). However as with the mammalian tmAC proteins, 
the results could not be reproduced in subsequent experiments.  
Therefore it emerged during the study that an important issue was the reproducibility of the 
mass spectrometry results, as in all the adenylyl cyclase experiments the results were 
variable and not very reproducible. Consequently when a fragment mass corresponding to 
a putative carbamylated residue appeared it was hard to have confidence in its identity. 
Although the inability to reproduce the results suggests that no carbamate was present, 
there are many other factors that could have influenced the outcome of the experiment.  
Firstly the conditions of the trapping experiment itself could have varied, for example 
fluctuating pH caused by the hydrolysis of the TEO could have affected the carbamylation 
status of the protein. Secondly the preparation of the sample for mass spectrometry could 
have introduced variability, for example during the trypsin digestion of the protein 
precipitate. Finally the mass spectrometry itself may have affected the results. The 
MALDI/TOF technique used has many advantages, chiefly that it is rapid, almost exclusively 
creates intact singly charged ions which aids data analysis, and is not largely affected by 
small amounts of contaminating salts (Domon and Aebersold, 2006). However it also has 
drawbacks including background signal from matrix ions,  and if the samples to be analysed 
are not completely uniform in the amounts of salts and other materials they contain this will 
also influence the results(Pan et al., 2007).   
Secondly although the experiment produced consistent results for haemoglobin this was 
after method optimisation, and it is possible that different conditions are needed for different 
proteins, depending on the positions of any potential carbamates. However it is hard to 
optimise an experiment for a protein unknown to form a carbamate. It is also possible that 
the trapping method will not work on some proteins, for example if the carbamate is 
inaccessible to ethylation by TEO.  Therefore in future the experiment should be tested 
using more positive controls for carbamylation such as Rubisco and β-lactamases to see 
how reliable it is in identifying trapped carbamates.  
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However the additional work needed to improve the trapping method and the mass 
spectrometry analysis was beyond the time constraints of this project. It was decided 
instead to further investigate the Rv1625c204-443  protein that was shown to potentially be 
carbamylated, using a different technique to mass spectrometry. The trapping experiments 
described in Section 5.0 were performed on Rv1625c204-443 proteins using radioactively 
labelled NaH14CO3 as the source of CO2. Mutating the K397 residue of Rv1625c204-443 to 
alanine showed no difference in the amount of carbamate bound, as would be expected if 
the K296 residue was responsible for carbamate formation as hypothesised. However 
mutating the K296 residue to alanine also showed no decrease in carbamate formation. 
This suggests that no carbamate was forming at this residue. Therefore it seems likely that 
the Rv1625c protein doesn’t form a carbamate at the substrate defining K296A residue, 
although the possibility of TEO not being able to modify this amino acid cannot be ruled out. 
It is also possible that the RV1625c protein could be forming a carbamate at another 
position. To establish this a robust negative control is needed for the 14CO2 trapping 
experiment, such as a mutation of the carbamate forming K201 residue of spinach Rubisco. 
Although other proteins not hypothesised to form a carbamate were used in the experiment 
as negative controls, the possibility that they did actually form one or more carbamates 
could not be ruled out. This was especially in this experiment the case as the results showed 
that all proteins did appear to form carbamates to some extent compared to controls where 
no TEO was present. This suggests that some level of ‘unspecific’ carbamylation may occur 
on all proteins, perhaps at very low levels. If this is the case it also requires further 
investigation, especially as no carbamates were detected by the MALDI experiments in 
Section 4.0, contradicting this theory. 
The high level of trapped carbamate on the Rx1 nucleotide binding protein was also an 
interesting find, as it is has not been previously found to have any association with CO2 
signalling or carbamate formation, and was originally intended as a negative control. This 
needs further investigation in future.  
Overall it has been shown that a carbamate trapping method has been developed for use 
on proteins and has been shown to work reproducibly on haemoglobin, though experiments 
on adenylyl cyclases were inconclusive. The method has several advantages over previous 
carbamate detection strategies; it removes the complications caused by trying to analyse 
unstable carbamate modifications, and being able to trap carbamates in the native 
conditions of the protein means results are more physiologically relevant and less prone to 
experimental artefacts.  
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6.2 Future work 
Future work still needs to be done to determine how to make results more reproducible. 
This should begin with the testing of more proteins known to form carbamates as positive 
controls in the mass spectrometry experiments, to enable the reproducibility and accuracy 
of the method to be determined. At least one negative control protein where the specific 
carbamate binding amino acid is mutated should also be used in future 14CO2 experiments, 
to establish whether proteins still show ‘background’ protein carbamylation. If so it should 
be determined whether this is a true result or if it is an artefact of the assay. The potential 
of the Rx1 protein to form a carbamate should also be investigated further, as it is possible 
that a new role for CO2 interaction with this protein could be discovered.  
The ultimate goal which the results from these experiments contribute towards is to be able 
to trap potential carbamates on multiple proteins at a time under physiological conditions, 
for example in the lysate of a cell. The trapped proteins could then be screened 
simultaneously using mass spectrometry proteomic techniques, and those found to form 
carbamate modifications identified and subjected to further analysis to elucidate the 
functions of the identified carbamates. Use of this screening technique will enable rapid 
discovery of proteins which form carbamate modifications, facilitating our understanding of 
the extent of the modification in physiology and the ways in which it functions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D) 
D) 
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